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ABSTRACT 
Design and optimization of flexural piezoelectric transducer for development of light weight 
wearable therapeutic ultrasound patch 
Youhan Sunny 
Advisor: Peter A. Lewin, PhD. 
 
 The goal of this work was to design, develop and fabricate a flat (<10 mm thick), 
lightweight (<100g), customizable, fully portable and wearable therapeutic ultrasound applicator, 
operating in the bandwidth 20kHz to 100kHz. This work specifically aimed at optimizing the 
flexural transducer performance, so the maximum acoustic output could be achieved with 
minimum excitation voltage, thus facilitating battery-powered operation. Such optimized design 
combination is not available as the currently used low frequency (<100kHz) ultrasound 
applicators are bulky, unwieldy and require heavy instrumentation along with the AC power 
supply as the excitation source. The unique design described makes the applicator clinically 
relevant and enables its operation at safe, FDA approved acoustic intensities (<100 mW/cm2 ISPTP, 
Spatial-Peak, Temporal Peak). 
 The design details along with the acoustic characteristics of the flexural transducer 
implementation that requires only 10-15V battery supplied driving voltage are described in this 
thesis. The transducer was tested as tether-free, wearable therapeutic unit in successful treatment 
of chronic venous- and diabetic ulcers in humans; the results of the successful human studies, 
performed with this applicator are also included.  
 CHAPTER 1: INTRODUCTION  
 
 The goal of this work was to design, develop and fabricate a flat (<10 mm), lightweight 
(<100g), customizable, fully portable and wearable therapeutic ultrasound applicator, operating in 
the bandwidth 20kHz to 100kHz.  This work specifically aimed at optimizing the flexural or 
flextensional transducer performance, so the maximum acoustic output parameters could be 
achieved with minimum excitation voltage, thus facilitating battery-powered operation. Such 
optimized design combination is not available as the currently used low frequency (<100kHz) 
ultrasound applicators are bulky, unwieldy and require heavy instrumentation along with the AC 
power supply as the excitation source. The unique design described makes the applicator 
clinically relevant and enables its operation at the safe, FDA approved acoustic intensities (<100 
mW/cm2 ISPTP, Spatial-Peak, Temporal Peak). 
This work describes the design, manufacturing and optimization flexural transducers for 
biomedical ultrasonic applications. The ultimate goal of this work was to fabricate a portable, 
fully wearable, low weight (<100 g) and battery operated piezoelectric ultrasound applicator 
providing maximum output pressure amplitude at the minimum excitation voltage. 
 
 Implementation of ultrasound applicators that can operate at the excitation voltages on 
the order of only 10-15 V is needed in view of the emerging evidence that spatial-peak temporal-
peak ultrasound intensity (ISPTP) on the order of 100 mW/cm2 delivered at frequencies below 100 
kHz can have beneficial therapeutic effects[1-3]. These therapeutic effects can be used to assist in 
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present wound care procedures and aid in the challenging healing process of chronic- venous [4] 
and diabetic ulcers. In addition, these effects have a potential to enable non-invasive, syringe-free 
transdermal delivery of drugs [5], and delivery of liposome encapsulated drugs [6]. 
 In this thesis, the term optimization refers to the overall performance of the flexural 
transducers and is defined as the process of maximizing the acoustic output pressure amplitude 
whilst minimizing the excitation or driving voltage required.  Acoustic performance was chosen 
as the primary parameter for optimization, as portability and wearability of the device is crucial 
for its clinical applicability and with the technology presently available this applicability is 
primarily determined by the number and size of rechargeable Li-Polymer batteries needed. Hence 
minimization of the electrical power (voltage and current) needed in order to produce the required 
acoustic output pressure amplitude was essential in the design process.  
 To gain insight into the optimization procedure described in the following it is useful to 
examine the current state of the art of low frequency (LF, 20 kHz-100 kHz range) transducer 
design and to identify the deficiencies impeding its immediate use in clinical applications. 
Although there exists substantial literature on the topic of flexural ultrasound transducers 
operating at frequencies below 100 kHz, in the following only the papers that were of direct 
relevance in the design and optimization procedure applied here are reviewed. As already noted, 
the ultrasound applicators considered in this work were intentionally designed for operation in 
20-100 kHz range and this is in contrast to the fact that the majority of therapeutic applicators 
operate in the frequency range 1-3 MHz. The choice of frequency of operation in this work was 
selected to be an order of magnitude lower than that reviewed in [7] and was prompted by 
emerging evidence that LF ultrasound exposure could be more effective than that in the 1-3 MHz 
range. Despite the fact that the distinction between the different ultrasound intensities such as 
spatial-peak temporal-peak (ISPTP), spatial-average temporal-peak (ISATP), spatial-average 
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temporal average (ISATA), and spatial-peak pulse-average (ISPPA), were not always given in [8], 
this review was considered to be of interest because it covered relatively wide interval of intensity 
levels ranging from 0.5 mW/cm2 to 3000 mW/cm2. Specifically, Mitragotri [9] and his co-
workers from Dr. Langer’s laboratory at MIT demonstrated in vitro that the therapeutic effects of 
ultrasound related to mammalian tissue were more prominent in the low (10-100 kHz) range than 
those observed at higher (1-10 MHz) frequencies [9]. However, implementation of the LF 
ultrasound treatment in clinical practice is still hampered by the fact that the acoustic sources 
capable of generating ultrasound energy in 20-100 kHz bandwidth are in general unwieldy, bulky, 
and require heavy (25+ kg) electronic setup; for example a typical applicator driver design 
described in [10] included a function generators weighing about 1-2 kg and the ENI Power 
amplifier weighing close to 25 kg. 
 In addition to the need of using bulky equipment, there is one more aspect that 
contributed to the lack of the availability of portable therapeutic ultrasound devices in this 
frequency range and prompted the departure from the conventional mode of design of 
piezoelectric, thickness-polarized materials. The conventional design utilizing fundamental mode 
of vibration, in which the PZT thickness is equal to half-wavelength (λ/2) at the resonance 
frequency, and the solid or composite PZT ceramic thickness has to be on the order of 20 mm at 
100 kHz and fivefold that at 20 kHz. Such thickness not only increases the weight and bulk of the 
ultrasound transducer, but more importantly, it requires excitation voltages exceeding 100 VRMS to 
produce acoustic output that could be considered clinically relevant, say on the order of 50-100 
mW/cm2 (ISPTP) as that employed in the human studies described in Chapter 5.  
 To circumvent these issues, Kost and his coworkers [11] proposed to employ a custom-
designed transducer, using a stacked-ceramic design. This 42 kHz transducer was used in the set 
of well-conceived experiments permitting the research team to conclude that the observed 
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sonoporation was due to inertial cavitation. Although the stacked ceramic design was capable of 
delivering ultrasound intensity exceeding 2.5 W/cm2 [11] it required 100 VRMS excitation voltage; 
that was achieved with the use of heavy power amplifier.  
 In contrast, the prototype applicator described here utilizes the flexural mode of vibration 
and produces much lower intensity (<100 mW/cm2 ISPTP). This low intensity, that – as evidenced 
in the following – was achieved with relatively low excitation voltages (12-15 VRMS), was 
intentionally chosen to prevent the onset of inertial cavitation.. Although flexural transducers 
were described as early as 1930's [12] their most practical implementation was proposed by 
Newnham and his Penn State team [13] almost five decades later. Their contributions are 
elegantly detailed in several scholarly publications [14], [15] and the PhD dissertations of 
Tressler [16] and Snyder [17]. These publications described an acoustic source, in which its 
individual elements could be arranged in 2x2 or 3x3 arrays referred to as moonie and cymbal 
transducers. Subsequently, these arrays were used in a successful non-invasive transdermal 
delivery of insulin using live pigs [10]. This in vivo result can be considered as a milestone in 
ultrasonically assisted drug delivery because it demonstrated that relatively low level (100 
mW/cm2 ISPTP, below the inertial cavitation threshold) of acoustic energy was sufficient to push 
large molecular weight (>5000 Da) particles through the stratum corneum, which is otherwise 
impermeable for particles of this size. However, the array used for insulin delivery in [10] also 
required excitation voltages exceeding 100 VRMS and the use of ancillary electronic setup 
including a 55 dB ENI power amplifier. As indicated earlier the weight of this instrument alone is 
about 25 kg and hence prevents any portable clinical application. 
 The flexural transducer proposed by Newnham [13], whose careful modification is 
described in this work, lends itself well for the generation of  frequencies in the bandwidth of 20-
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100 kHz considered as low frequency in this work. The design described in this work offers not 
only portability but also a fully wearable implementation of the device, making it a viable and 
clinically applicable therapeutic ultrasound applicator. Its systematic step-by-step development 
including analysis of electromechanical parameters is presented in this thesis. As already noted 
the ultimate goal of this research was to develop a transducer that would deliver maximum 
displacement amplitude with the lowest possible excitation voltage and be capable of tether-free, 
self-contained battery operation for 4-5 hours (considered clinically relevant).  
 The specific aims of this thesis are listed in the next section, and in the following chapters 
a wearable implementation of a flexural transducer based therapeutic ultrasound applicator, 
producing clinically relevant acoustic output in the considered bandwidth of 20-100 kHz is 
discussed, along with key parameters governing the acoustic output and frequency. The design 
and implementation of a practical clinical therapeutic ultrasound applicator prototype is followed 
by a succinct summary of the experiments, the data obtained with the optimized design, and 
future recommendations. 
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SPECIFIC AIMS  
Specific Aim 1: to Analyze the flexural transducer design in order to control the low frequency 
resonance and to maximize the voltage to pressure conversion. 
 The ultrasound applicator designed in this study employs conventional piezoelectric 
ceramic disc made of PZT (Lead Zirconate Titanate (Pb[ZrxTi1-x]O3 , 0≤ x ≤1).  In the sandwich 
structure depicted in Figure 5, when activated by an external voltage signal the applicator 
combines the fundamental thickness mode of vibration with the radial displacement to produce an 
amplified (in comparison with the displacement amplitudes generated by each mode individually) 
displacement amplitude. Such structure also introduces a low frequency (tens of kHz range) 
resonance in addition to the higher frequency (MHz range) thickness mode resonance of the PZT.  
Specific Aim 2:  Optimize the physical geometric and electrical parameters of the transducer and 
the manufacturing process to maximize the conversion of input voltage to output pressure 
amplitude efficiency, defined in this work as Pressure/ Voltage (Pa/V). 
The optimization parameters include physical properties such as PZT material and end cap 
material, geometry of the active PZT element such as diameter and thickness. The geometry of 
the shaped metal disc (shape, height, inner and outer diameter as shown in Figure 10 to Figure 
13) was also one of the parameters governing the final transducer characteristics achieved in the 
design process. Finite element analysis software COMSOL, was used to model the transducer and 
evaluate the effects of the above-mentioned parameters on the frequency, displacement 
amplitude, field distribution and acoustic output in terms of pressure amplitude [kPa] and 
intensity [mW/cm2].  
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Specific Aim 3: Develop a complete, clinically applicable, tether-free, lightweight ultrasound 
applicator patch, which is portable, wearable and battery operated.  
 Completion of Aim 1 an Aim 2, allowed the development of a therapeutic ultrasound 
applicator patch that the users can conveniently wear without impediment in their day-to-day 
activities. In addition to constructing and testing the designed optimized transducer, aim 3 also 
includes developing an electronic driving system that permits the output (excitation) voltage to be 
adjustable. This adjustable excitation voltage allows the delivered ultrasound energy levels to be 
controlled in such a way that the patients are exposed to beneficial effects, while ensuring the safe 
operation of the applicator. Rechargeable batteries, as noted above, power this driver circuitry, so 
that the patient can move freely. The applicator also works sufficiently long  (2-3 hours) before a 
recharge is needed, so that the ultrasound therapy treatment can be performed outside the clinic at 
the patient’s home.  
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CHAPTER 2: BACKGROUND AND SIGNIFICANCE 
 
 This chapter includes a short description of the evolution of flexural transducers and a 
summary of the relevant research on low frequency, low intensity (LFLI) ultrasound for 
therapeutic uses. To reiterate, this work was focused on the development and optimization of an 
un-tethered, low voltage, 20-100 kHz flexural ultrasound applicators that can be implemented as 
a fully wearable, light-weight (<100 g), and re-chargeable battery operated devices. Such devices 
are not currently available; also, such an implementation of a therapeutic ultrasound applicator is 
also important in view of the emerging evidence that spatial-peak temporal-peak ultrasound 
intensity (ISPTP), on the order of 100 mW/cm2 delivered at frequencies below 100 kHz can have 
beneficial therapeutic effects. These effects (discussed in more detail in the following) include, 
for instance, wound management of chronic ulcers and non-invasive, transdermal delivery of 
insulin and liposome encapsulated drugs [4-7]. The emerging evidence on the clinical relevance 
of low frequency low intensity  (LFLI) ultrasound and the absence of practical, i.e. clinically 
applicable ultrasound sources in the LFLI range both warrant the need for the work described in 
this thesis.  
The concept of a flexural transducer was proposed and patented by Hayes in 1936 [18], and this 
patent described transducers with metal shells or casings of various shapes, in different 
arrangements, and in combination with active magneto-restrictive element, which was designed 
to produce sound in the audible range. The patent by Hayes [18] described the basic operation of 
the flexural mode; the vibration of the active element coupled firmly with the metal shell 
translated the vibratory motion of the active element to the metal housing (case). The devised 
construction resulted in amplifying the displacement amplitude of the active (in [15], magneto-
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strictive) element due to the induced augmented displacement amplitude of the metal shell or cap.  
There are five possible modes of operation depending on the specific geometry or architecture 
between the active piezoelectric element and the metal element. However, for the applications 
targeted in this study only one of these modes referred in [18] as class V is of relevance here. 
Accordingly, as the optimization of the ultrasound applicator employed here was performed using 
only this approach and is described in detail in the following sections, which provide the 
background knowledge that was needed to finalize the design and fabricate the working 
prototypes.  
2.1 ELECTRO-MECHANICAL TRANSDUCERS 
 
Figure 1 shows the class five (V) flextensional transducer designed by Hayes, which uses a 
magneto-striction device, with an oval shaped metallic shell, attached to the active element at its 
either sides [12]. Figure 2 shows class five (V) design modified by Toluis [19], which employs 
stacked design, and has a stack (instead of a single device ) of active elements in the center of an 
oval ring shaped metallic shell. In comparison with the single device, the stack, produced larger 
value of force and displacement, and hence resulted in a higher energy output from the 
transducer. 
 
 
 
 
Figure 1: Flexural design by Hayes, showing the mechanical active element in the center, 
with metal shells on either side 
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Both of these transducers were designed to operate in the audible range (< 20 kHz) [12, 19] of 
frequencies; the design developed here was intentionally targeting frequencies of operation above 
the 20 kHz mark (audible range).  
2.2 PIEZOELECTRIC TRANSDUCERS 
 
With the advent of men-made piezoelectric materials, such as Barium Titanate and Lead 
Zirconate Titanate or PZT, Frank R Abbott, in 1959, patented the design [16] that could be 
referred to as the early predecessor of moonie and cymbal transducers (discussed later), which 
constituted the direct basis of the applicator devised here. Abbott’s design made use of a convex 
or concave metal disc, in conjunction with a magneto-restrictive, electro-restrictive or ring-shape 
piezoelectric material, to produce sonic (in loudspeaker configuration, see Fig. 3) or supersonic 
(up to 100 kHz) frequencies.  
 
Figure 2: Flexural design by Toulis, showing the stacked ceramic active element, enclosed 
in an oval metal case 
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As already alluded to, the design of Figure 3 [20] resembles the moonie and cymbal designs 
patented by R.E. Newnham [13], and as discussed in the next  chapter, it is this design that was 
carefully improved in this  work.  
 
2.3 SIGNIFICANCE OF THERAPEUTIC APPLICATIONS 
 
 Prior to discussion of the design approach used here to fabricate the ultrasound applicator 
prototype, it might be useful to succinctly review the targeted applications. This review is helpful 
in identification of the criteria that were needed to be examined and satisfied in order to optimize 
the applicator design.  
As already noted low frequency, low intensity (LFLI) ultrasound in the frequency range 20-100 
kHz was shown to be effective as a therapeutic tool. The selected, relevant applications are 
discussed in the following. It should also be noted that although the applicator described in this 
study was expressly designed for application in chronic wound management and transdermal drug 
Figure 3: Flexural design by Abbott , shows the ring shaped piezoceramic bonded to shaped 
metal caps 
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delivery, the potential applications of this device are not limited to these; other possible 
application areas include pain management [7, 21], and nerve stimulation [22], See also Future 
Recommendations) . Below, a brief description of the two application areas where the applicator 
was actually tested, namely enhanced healing of chronic wounds (venous and diabetic) and non-
invasive, transdermal drug delivery of anti-arthritis medicine is given. 
 
CHRONIC WOUNDS 
 
 
Again, to gain insight into the design applicator’s criteria a fundamental knowledge of 
chronic wound origin and management is essential. Briefly, chronic venous insufficiency is a 
medical condition in which the veins of the lower extremities are compromised. Venous reflux, 
due to incompetent valves, leads to venous hypertension and eventually chronic venous 
ulceration. Chronic venous ulcers pose a substantial threat to a patient’s quality of life as well a 
substantial financial burden. The annual treatment and management of these wounds exceeds $14 
billion, with additional indirect costs associated with limited productivity and mobility issues 
related to pain and depression [23]. Each year, over half a million people in the United States are 
affected by chronic venous ulcers, accounting for approximately 1% of the total health care cost 
and resulting in the loss of up to 2 million work days [24, 25]. The negative impact on the quality 
of life of patients and the prevalence and cost of care associated with chronic venous ulcers make 
the cost-effective treatment of such wounds an important contemporary issue.  
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It is appropriate to note that low frequency ultrasound has previously been proposed as a 
therapeutic tool for chronic venous ulcers. In two studies published in 1997, low frequency (30 
kHz), low intensity (100 mW/cm²) ultrasound (no temporal and spatial information was provided, 
though) was applied through a water bath to venous leg ulcers [26, 27]. Both the studies reported 
that the size of treated wounds decreased more rapidly than control wounds, however, these data 
were obtained with a stationary, non-movable equipment (ultrasound bath). 
More recently, a non-contact ultrasound device was used to treat chronic foot and leg 
ulcerations of different etiologies, including venous ulcers [28, 29], but the design of this device 
was focused on remote debridement of the wounds.  
ARTHRITIS 
 
In addition to the chronic wound healing treatment the applicator developed in the course of this 
work was used to explore its usefulness in minimizing the adverse side effects in standard 
treatment of rheumatoid arthritis (RA).   
Rheumatoid arthritis (RA) is a chronic, debilitating inflammatory, musculoskeletal 
disease that affects 0.5-1.0% of the adult population in Western countries, with total treatment 
costs approaching $80 billion annually [30, 31].  Its pediatric sibling, Juvenile Idiopathic Arthritis 
(JIA) affects 0.01-0.4% of children [32]. The joint destruction and progressive functional 
disability associated with uncontrolled inflammation impact ability to work, attend school, overall 
quality of life, and mortality [33, 34].   
 Systemic Corticosteroids (CS) most often control disease in inflammatory arthritis, RA 
and JIA.  However, if given for a prolonged period, they result in significant morbidities, 
including glaucoma, cataracts, weight gain, hypertension, diabetes, and bone fragility [35, 36]. 
Therefore, alternate systemic agents, are added to spare exposure to steroids. These include: 
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hydroxychloroquine, disease modifying agents (e.g. methotrexate), non-steroidal anti-
inflammatory agents and andbiologic agents [37-39].  These non-steroidal agents often lead to 
side effects including, cytopenias, increased risk of infection, and pain (subcutaneous 
injections).  While biologic agents may be helpful in recalcitrant disease, they typically cost 10 to 
100 times more than older therapies, and there has been a global concern regarding their impact 
on burgeoning healthcare budgets [30]. The primary goal of transdermal delivery is to minimize 
the side effects of the drugs taken systemically or injected intra-articularly while maximizing 
their potency in alleviating arthritis. 
Intra-articular CS injections (IACI) are preferred over systemic agents to treat mono-
articular/oligoarticular arthritis [40]. Although intra-articular administration of CS derivatives can 
result in rapid onset of a durable anti-inflammatory response that may limit or obviate exposure to 
systemic medications [37, 41-43], alternative effective but non-invasive ways to deliver local CS 
are needed. The fully wearable, battery operated ultrasound applicator described here alleviates 
these issues. In particular, as already noted, it might provide a painless route of treatment, while 
minimizing side effects. It also offers a potential for home treatment without the need to visit the 
physician’s office. This, in turn, will potentially enhance the patient’s quality of life and by 
eliminating the need for transportation to the hospital, further lessen the cost of treatment.  
The research in ultrasound assisted drug delivery has gained increasing attention over the 
past two decades.  While there is a bevy of publications on the topic, here, for brevity and 
convenience, only one extensive and systematic review describing the current knowledge and 
state-of-the-art of US assisted drug delivery is highlighted. This recent, well-documented (with 
181 references) survey was published by the team of researchers from Ben Gurion University, 
Beersheba, Israel [44]. The information provided therein [44] should be helpful in facilitating an 
insight into the encouraging outcome of the in vivo animal study described in the following. 
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 The applicator described in this work offers flat, thin (< 10 mm) and light weight 
alternative to the bulky transducer designs that are currently used for ultrasound therapy at low 
frequency (20-100 kHz). Applications such as wound management of chronic ulcers and non-
invasive, transdermal delivery of insulin and liposome encapsulated drugs [4, 5, 7] will be 
facilitated by the development of such a prototype applicator as described in this study. The 
design and optimization process of the ultrasound applicator, that was used subsequently in 
healing of chronic wounds in human patients and in examining the feasibility of enhanced 
transdermal, syringe-free drug delivery are described in the following chapters. 
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CHAPTER 3:  FLEXURAL TRANSDUCER: PRINCIPLE OF OPERATION 
AND OPTIMIZATION  
 This chapter describes the basic operation and design of flexural transducers, and gives a 
detailed explanation of the finite element analysis that was performed to design and optimize the 
flexural transducer. The finite element analysis was performed using COMSOL software, and a 
step-by-step analysis of the parameters that control the transducer operation was performed. 
3.1 PRINCIPLE OF OPERATION 
  
This section enhances information presented in Chapter 2 that introduced the 
fundamental principle of operation of the very early flexural transducer design [18, 45-47] and 
focuses on the selection and performance of the active element that was used in the optimization 
process, namely the PZT ceramic disc (see Figure 5 for details).  
 To fully appreciate the operation of the flexural transducer, it is necessary to consider 
piezoelectric effect and flexural mode of operation and how these two components work together. 
Piezoelectricity, discovered by J. and P. Curie in 1880, refers to the ability of certain crystalline 
materials to develop an electrical charge proportional to a mechanical stress exerted on the 
surfaces and – vice-versa - a geometric strain or deformation proportional to an applied voltage. 
Materials exhibiting such property are called piezoelectric materials. There are several naturally 
occurring piezoelectric materials like quartz and Rochelle salt [48, 49] but these crystals only 
exhibit a weak (2.2 pC/N compared to 350 pC/N for PZT-4) piezoelectric effect, and are not 
suitable for industrial applications. Artificially manufactured piezoceramics like Barium Titanate 
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and Lead Niobate, Lead Titanate exhibit a much stronger piezoelectric effect [48, 50] and can be 
manufactured in a variety of sizes and shapes such as discs, rings, rods, hollow cylinders, 
rectangles and machine diced arrays.  Lead Zirconate Titanate (PZT) is the most commonly used 
piezoceramic and its chemical composition is (Pb[ZrxTi1-x]O3 , 0≤ x ≤1). The zirconate-titanate 
ratio of x: (1-x) controls the piezoelectric properties of the ceramic such as dielectric strength, g33 
(g, the piezoelectric voltage constant, and is defined as the electric field [V] generated by a 
piezoelectric material per unit of mechanical strain experienced by a piezoelectric material) and 
d33 (d, the piezoelectric charge constant, is the mechanical strain experienced by a piezoelectric 
material per unit [V] of electric field applied). Only certain stoichiometric values of x will result 
in a stable and usable PZT ceramic, and based on this information several manufacturers have 
fabricated different types of PZT, that exhibit somewhat different electromechanical properties 
(see Table 3). The applicators optimized in this work utilize Navy type I or PZT-4 ceramic as this 
type is best suited for acoustic source or transmitter applications (see Table 3: PZT properties). 
The basic flextensional transducer design shown in Figure 4 (after the PhD thesis written 
1988 by Aydin Dogan, Pennsylvania State University [51])  comprises of a piezoelectric element, 
of appropriate thickness (thickness controls partially the frequency of vibration) and shaped metal 
discs. These discs are 'cymbal' shaped in case of cymbal transducer, and hemispherical with flat 
lips for bonding to the PZT at the edge, for the moonie transducer. The discs are bonded on both 
sides of the PZT ceramic. The design presented in [51] was chosen as the starting point for the 
design and optimization described here, because it describes the most recent work that was done 
to improve the flexural transducer design.  
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The principle of operation of the design described in [47] (saliently summarized below) 
was scrutinized - and each component that contributed to the displacement amplitude of the caps 
(see Figure 7 to Figure 13) was carefully analyzed and modeled.  The outcome of this process 
provided the design of the flexural transducer that was used to develop the therapeutic applicator 
used in the clinical trials summarized in Chapter 4 and 5. 
As shown in Figure 5 the active element, piezoelectric (PZT) ceramic, converts the 
voltage applied across its thickness, into a change in its dimensions. When an excitation voltage 
is applied across the faces of a flexural transducer (PZT used in this work is disc shaped and 
thickness poled), its thickness and radial dimensions change and the total displacement amplitude 
is dependent on the combination of the PZT movement and the resultant flexural motion of the 
bonded metal discs. The motion or change in dimensions of the piezoceramic can be determined 
using the d constant, d33 (PZT-4: d33 = 300 x 10-12 m/V). The d33 describes the amount of change 
in meters, per volt of excitation. The other constant associated with PZT that is of importance 
here is d31 and it represents the change in length and width dimensions. As the PZT used in this 
work is disc shaped, d31 acts in the radial direction. The two constants, d33 and d31, act in 
perpendicular directions (d33 along the Y axis, and d13 along the X axis, in Figure 5). Typical 
value for d31 in PZT 4 (used here) is -125 x 10-12 m/V (see Table 3: PZT properties). This 
Figure 4: Flexural motion in moonie and cymbal transducers 
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indicates that, in a given cycle (say negative) of the excitation voltage, the dimension change 
perpendicular to the ceramic face (Y axis) results in an increase of the thickness, whereas the 
corresponding dimension change in the radial direction (X axis) is the very opposite, i.e. it leads 
to a reduction in the radius. For a disc type PZT, the total dimension change along the diameter is 
proportional to 2*d31 because of the axial symmetry and half wave fundamental thickness 
operation. 
 
 
In Figure 5, the rectangle represents the cross sectional view of the PZT-4 ceramic disc of 
thickness t (Y axis) and the “thin” arrows mark the radial direction (X axis) of the change in 
dimension (radial contraction) of the PZT disc. The arrows in the Y axis direction are thicker, and 
indicate that the displacement amplitude is produced in that direction (perpendicular, because of 
the thickness poling of the PZT disc) to the ceramic face. The radial component contributing to 
the overall displacement (and hence to the resulting pressure amplitude of the wave) is relatively 
small (less than half) in comparison to the perpendicular displacement amplitude. For a given 
sound velocity (see Table 3) the fundamental mode resonance frequency of the PZT-4 disc of 
Figure 5 is determined by the thickness t = λ/2.  
Figure 5: Basic construction of the single element applicator 
optimized in this work. 
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In the design of Figure 5 the dotted lines show diagrammatically the axial, (along Y axis) 
displacement amplitudes that are targeted to be maximized. As mentioned earlier, these 
displacements are caused by the flexural mode of operation, which utilizes the changes in the 
geometrical dimensions (along both X and Y axes) of the active PZT element. The appropriately 
shaped metal caps through their flexural motion convert the radial displacement into an axial 
motion. More specifically, the radial inward motion of the PZT causes the apex of the metal caps 
to move along the Y axis (see Figure 5 and Figure 6). As this takes place, in addition to the 
displacement of the apex (along Y axis) caused by the thickness mode of vibration, the flexural 
motion of the cap apex as a result of the radial motion (along Y axis) is added to the overall 
displacement amplitude. This combined displacement this is larger than it would have been due to 
any single (radial or thickness) displacement alone.  The edges of the metal caps are bonded to 
the piezoelectric disc, so they must follow the displacement of the PZT ceramic. Thus, when they 
move radially inwards, the bottom of the slanting edge is also pulled in the same direction. This 
deformation pushes metal caps apex along the Y axis, and is called flexural motion. Overall, the 
design shown in Figure 5 acts as displacement amplitude amplifier and – the pressure amplitude 
(Pa) is directly proportional to the displacement amplitude of the metal caps. 
In line with the considerations presented above, the PZT-4 (Navy type I) ceramic was chosen to 
serve as an active element for the applicators described in the following. This ceramic type 
exhibits relatively large value of d33 ( ~ 300 x 10-12 m/V) and  d31 of ~125 x 10-12 m/V (Table 3,  
[52]), and low (0.6) loss tangent; hence it is best suited for applications as the source 
(transmitter).  
The total displacement amplitude can be expressed as being directly proportional to the sum of d 
constants [15] :  
Displacement α d33 + 2* |d31|.   
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This relationship is often referred to as hydrostatic piezoelectric constant dh [53] and indicates 
that the overall displacement amplitude produced by the flexural transducer, is larger than that 
achievable with the freely vibrating PZT disc, alone.  This mode of operation of the applicator, 
enables it to produce acoustic pressure amplitude of (50-60 kPa, see chapter 5) at relatively low 
frequencies (<100 kHz). This would not have been possible using a conventional λ/2 thickness 
mode of vibration because the fundamental resonance frequency of a 1 mm thick PZT disc (see 
section 3.1) is 2 MHz.  Hence, the 20 kHz fundamental mode design would require the use of 40 
mm thick PZT disc. The weight of such disc alone would be about ~1kg, (2.π.r2.h.ρ, 12.7mm 
diameter, 40 mm height and 7500 kg/m3 density) and would be prohibitive for use as wearable 
clinical device. In addition, such thickness would have required excitation voltages on the order 
of hundreds of volts making the use of batteries impossible.  In contrast, the optimized flexural 
design described in the following enabled design of light (100 g), clinically applicable and fully 
wearable, battery powered device.  
 
 
Stage 0: Rest or Non-excited State - occurs at zero crossing of the excitation voltage 
Stage 1: Max Vertical displacement - occurs at positive cycle (peak) of the excitation 
Stage -1: Min vertical displacement (Max radial extension) - negative cycle (peak) of excitation. 
             
Figure 6 : Stages of end cap displacement corresponding to excitation voltage 
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 Figure 6 shows in more detail the principle of operation of the applicator by depicting the 
temporal displacement of the metal caps during one sinusoidal excitation cycle. The positive half 
cycle activation voltage causes the metal cap to move outwards in the axial +Y direction, 
producing the positive pressure wave amplitude, and the reverse happens during the negative 
half-cycle phase, i.e. the metal cap moves along the axial (Y) direction in the -Y direction, from 
its steady state (corresponding to zero crossing), to result in the negative pressure wave 
amplitude. The structures shown in Figure 5, Figure 6 and Figure 7 were used in the development 
and optimization of the flexural ultrasound transducer (applicator) developed in the course of this 
research. 
 
3.2 TRANSDUCER MODELING AND PARAMETER OPTIMIZATION 
   
This section describes the finite element analysis (FEA) of the flexural transducer in 
order to identify the parameters (Table 1) associated with its manufacturing, including various 
PZT materials and metal disc parameters, that govern the transducer performance. As already 
mentioned, optimized transducer is defined here as a transducer that operates at any given 
frequency (20 kHz to 100 kHz) while delivering 55 kPa peak to peak pressure amplitude at the 
lowest possible input voltage.  
 FEA allows numerical solving of complex partial differential equations that are used to 
describe the physical behavior of a modeled system.  FEA employs a system of points, referred to 
as nodes, which are generated by a grid (mesh) that represents the geometry of a system 
considered. This modeled system can then be analyzed after the appropriate assignment of 
material properties and boundary conditions and the dynamic behavior of the overall system can 
be predicted. As mentioned above, the structure being modeled is divided into a mesh of many 
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elements, intersections of these elements are referred to as nodes and the analysis is run on each 
of the element’s nodes for the entire model. The FEA of the flexural transducer used in the 
ultrasound applicator described here was performed using COMSOL Multiphysics software 
package version 4.2 with the MEMS and Acoustic modules. This version allowed all of the 
parameters of interest to be considered.  Specifically, COMSOL version 4.2 offers different types 
of analysis options for piezoelectric device simulations including eigenfrequency, frequency 
domain, stationary, and time-dependent analyses. In the simulations described below, 
eigenfrequency analysis was carried out in order to determine the resonance frequencies of the 
flexural transducer and frequency domain studies were used to compare the reactance spectra 
plots with both those available in the literature [54] and those obtained experimentally from the 
fabricated prototypes [55]. After experimental verification, stationary and eigenfrequency 
analyses were performed in order to optimize the applicator design. 
3.3 FEA PROCEDURE 
 
The three-dimensional exploded view of a single flexural element used in the ultrasound 
applicator is shown in Figure 7. It is rotationally symmetric about its centerline and therefore 
lends itself well to two-dimensional axis symmetric modeling. Accordingly, two-dimensional 
axisymmetric modeling was chosen as it allowed the high (1000 fold more time consuming) 
computational cost associated with three-dimensional modeling to be minimized. The 
components of the applicator that were considered in the systematic, step-by-step analysis can be 
divided into three broad categories: piezoelectric materials, adhesive epoxy, and shaped metal 
caps. The physical properties of the metal and the piezoelectric materials that were modeled were 
taken from COMSOL’s material library. The adhesive epoxy material properties were obtained 
from the technical data sheet (Stycast 2741 LV / Catalyst 15 LV, Emerson and Cuming) and the 
thickness was fixed to be 20 microns.  The reason for choosing this thickness and epoxy type was 
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based on earlier published data [16]; Tressler suggested to keep the thickness of the bonding 
epoxy between the metal cap and the PZT ceramic as approximately 20 microns for the purpose 
of modeling, to minimize its effect on the acoustic output characteristics. The purpose of the 
epoxy is to bond the metal and the PZT disc and a thin layer (~20 micron) is adequate for this 
purpose while ensuring electrical connection. The influence of the architecture  of metal caps' and 
piezoelectric element dimensions were examined with FEA modelling. All of the piezoelectric 
disc material types that were analyzed during the optimization process were of the lead zirconate 
titanate ceramics (PZT) family (see PZT modeling section) and were poled in the thickness 
direction.  
 The primary goal of the modeling was to determine the geometric parameters and 
material properties that control the acoustic output of the flexural transducer. In other words, the 
modeling was performed to facilitate the optimization process, to determine the ideal set of 
parameters that would lead to an optimized transducer, i.e a transducer that would produce the 
maximum acoustic pressure output (displacement amplitude) using minimum excitation voltage. 
The parameters that were modeled are given in Table 2 and included:  
1. Piezoelectric disc dimensions 
2. Cap material 
3. Cavity depth 
4. Metal thickness 
5. Base radius 
6. Apex radius  
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 The metal caps that were fabricated and modeled in this work were chosen to have the 
same overall radial dimensions as the PZT discs. Due to manufacturing design constraints, (which 
required adequate bonding surface area for the metal caps to adhere to the PZT), in the 
simulations, the base radius of the shaped metal cap (Figure 7) was modeled such that there was 
at least a 1 mm ring of bonding surface between the PZT disc and the metal cap (bonding epoxy 
width). The metal cap apex radius was modeled such that the difference between the apex radius 
and the base radius was at least 1 mm and this was done to ensure that the metal cap retained a 
“truncated cone” shape (Figure 7) which was required for the desired flexural motion [16].  
 Another important aspect of the FEA study was the assignment of appropriate structural 
and electrical boundary conditions. Three structural boundary conditions were considered, one 
that fixed the model about its rotational axis, another that was applied along the horizontal center 
of the PZT disc (prohibiting rotational movement), and finally, the one ensuring "free" movement 
everywhere else. The electrical boundary conditions were implemented by placing a voltage 
terminal on the top and a ground terminal on the bottom surface of the PZT disc, respectively. 
 As pointed out earlier, in order to verify the model the initial finite element analysis was 
performed with the same geometric dimensions and materials as those reported in [56]. The 
analysis presented in [56] was performed using a different FEA software (ANSYS) and the 
comparison of the eigenfrequencies obtained using COMSOL and ANSYS corroborated the 
validity of the analysis applied. Further verification of the model was obtained by comparing 
simulated data and experimental data. More specifically, the eigenfrequencies and the reactance 
(complex impedance) spectra were modeled using the COMSOL software for a selected 
geometry, piezoelectric material, and adhesive epoxy.  Next, the prototype, similar to the one 
described in [57], was fabricated and its resonance frequency was measured using AIM 4170C 
antenna analyzer (Array Solutions, Sunnyvale, Texas USA). The experimental and simulated 
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results compared well (to within 5%); this agreement was deemed sufficient to confirm the 
validity of the model.     
 
Figure 7: Flexural transducer modeling 
 
a) Three-dimensional exploded view of a single flexural element. 
b) Two-dimensional axisymmetric model with mesh used in FEA analysis.   
c) Two-dimensional axisymmetric model showing normalized displacement  
d) Ultrasound applicator prototype [57] (3x3 array). 
 e) Photo showing prototype 2x2 array applicator being worn on the forearm.  
f) Top-half two-dimensional slice of single flexural element  
 
Once the COMSOL model was verified, stationary and eigenfrequency analysis was performed 
on the flexural transducer model. As already noted, the ultimate goal of the simulation was to 
b 
c 
a 
d 
f 
e 
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determine the geometry and material components providing maximum pressure amplitude at a 
given frequency while using minimum voltage excitation.   
 
The results presented below pertain to a design that operates at 20 kHz.  This frequency was 
initially chosen because it is the only frequency that was successfully used in vivo for transdermal 
non-invasive insulin delivery in piglets [58], however optimization results were also obtained for 
prototype designs operating at 100 kHz.  A frequency range (20 – 100 kHz) was investigated in 
order to have multiple designs such that the applicators’ clinical treatment efficacy (in relation to 
the frequency) could have been evaluated and optimized. In the following the results of analysis 
of the geometric and material parameters of the metal caps and the PZT are presented. The 
geometric parameters of interest (Figure 7), which included those of the PZT disc (thickness and 
radius) and the metal cap (thickness, base radius, apex radius, and cavity depth), were also 
examined.  Analyses on the FEA model were performed varying all of the aforementioned 
geometric dimensions for both stationary and eigenfrequency analysis. After the modeling 
components were analyzed and the active element set to be PZT-4 (and brass for the metal end 
caps (see modeling section for more details on material selection) the geometric parameters of 
interest were varied to obtain the optimized design. For the stationary studies a maximum axial 
displacement amplitude was determined at the center of each metal cap with 100 V applied. The 
voltage choice for this modeling was arbitrary as the results scale linearly with the applied 
voltage (the final fabricated prototype operated with 15V excitation [57]).  The modeling results 
are presented in the next section.  
 
 
 
  28 
3.4 MODELING RESULTS         
 
This section contains the detailed descriptions of considerations leading to the final 
selection of the applicator’s components for design optimization. 
 
PIEZOELECTRIC MATERIAL TYPE AND THICKNESS  
 
Only piezoelectric ceramics that were commercially available, relatively inexpensive, and 
easy to procure (< 2 months lead time) were analyzed. It is conceivable that recent advances in 
composite ceramic and single crystal ultrasound transducers could potentially provide a more 
optimized design alternative than the PZT ceramics described here [59-61]. However, as 1-3 
composite PZT ceramics and single crystals are relatively expensive and difficult to procure they 
were not analyzed in the course of this work. Also, due to a recent directive in the European 
Union attempting to phase out lead usage [62], lead-free ceramics that are currently under 
development [63] could potentially replace PZT ones; again, they were not investigated here. The 
electromechanical properties for the standard PZTs were obtained from the manufacturer’s data. 
(See Table 3: PZT properties ) 
 The geometry of the PZT disc (thickness and radius) also determines the achievable 
displacement amplitude. As shown in Figure 8 the displacement amplitude is inversely 
proportional to the PZT disc thickness for a given PZT disc radius. For example with a 10 mm 
radius PZT disc, lowering the thickness from 3 mm to 0.5 mm results in a 4 fold displacement 
amplitude increase from approximately 3 µm to 12.5 µm. Although the results of modeling show 
that 0.25 mm thickness would further increase the displacement amplitude 1 mm thick discs were 
  29 
chosen to minimize the tradeoff between fragility (due to the brittle nature of the PZT) and 
mechanical compliance of the ceramic material.  
 
Figure 8:  Influence of PZT disc thickness on relative displacement  
 
 Figure 8 shows how the thickness of the PZT disk affects the displacement amplitude 
produced by the flexural transducer. It can be observed from the figure that the displacement 
amplitude goes down as PZT thickness increases, and that the displacement amplitude increases 
as the radius of the PZT disk increases. 
METAL CAP MATERIALS  
 
 Influence of different metal cap materials on relative displacement amplitude compared 
for a constant geometry is shown in Figure 9. A constant geometry (PZT disk radius: 6 mm, base 
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radius: 5 mm, apex radius: 1 mm, cavity depth: 0.2 mm, cap thickness: 0.125 mm) was chosen for 
presentation of the analysis although other geometries were also analyzed and the trend was 
found to be similar for all of the metals considered.  For the modeling condition shown in Figure 
9 the maximum displacement amplitude was obtained for aluminum, however in the following 
analysis brass was used.  This was because the availability of brass and the relative ease of cutting 
and shaping the metal cap for experimental prototypes.   
 
 
Figure 9: Influence of different metal cap materials on relative displacement amplitude  
  
 Figure 9 depicts the relationship between the displacement amplitude of a flexural 
transducer and different cap material properties, for a constant geometry (PZT disk radius: 6 mm, 
base radius: 5 mm, apex radius: 1 mm, cavity depth: 0.2 mm, cap thickness: 0.125 mm).  It can be 
seen from the figure that aluminum, brass and titanium offer the maximum displacement 
amplitude, among the metals modeled. 
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METAL CAP CAVITY DEPTH AND THICKNESS  
 
The cavity depth in Figure 10 is defined as the distance between the PZT ceramic face 
and the apical planar region of the shaped metal cap (shown in Figure 7).  The displacement 
amplitude depends on the cavity depth for a given PZT radius and metal cap thickness. 
Appropriate depth selection results in up to a three-fold increase in displacement amplitude for a 
given PZT radius.  For example in Figure 10 a for a PZT radius of 10 mm there exists a peak in 
maximum displacement amplitude which was found to be 12+ µm at a cavity depth of 
approximately 0.175 mm.  The graphs (Figure 10 a and Figure 10 b) showing cavity depth versus 
displacement amplitude illustrates that the maximum displacement amplitude appears at different 
cavity depths depending upon the thickness of the metal cap that is used. The maximum 
displacement amplitude was obtained for dimensions of approximately 0.175 mm cavity depth for 
metal cap thickness of 0.125 mm and approximately 0.325 mm cavity depth for metal cap 
thickness of 0.25 mm (the remaining geometric dimensions were fixed (see Figure 10 for details).  
Inspection of Figs. Figure 10-a (metal cap thickness 0.125 mm) and Figure 10-b (metal cap 
thickness 0.25 mm) reveals that with increasing thickness of the metal cap the cavity depth that is 
necessary for maximum displacement also increases.  It is worthy of noting that decreasing metal 
cap thickness from 0.3 mm to 0.125 mm results in increasing of the displacement amplitude 
(Figure 11). The analysis performed indicated that 0.125 mm thick metal caps were most practical 
for use in the prototype fabrication [57] because the sheets of 0.125 mm are commercially 
available. Also, the machining of the shaping die that was used for their fabrication was 
simplified. 
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Figure 10: Influence of metal cap cavity depth on the relative displacement. Figure 10 a : .125 
mm metal thickness, 10 b: .25 mm  metal thickness.   
 Figure 10 summarizes the effects of metal cavity depth on the displacement amplitude of 
flexural transducers. PZT disks modeled had radii varying from 3 to10 mm for metal cap 
thickness of: a) 0.125 mm thick disk shows the maximum displacement amplitude (over 12 µm) 
at approximately 0.175 mm cavity depth. b) 0.25 mm thick disk shows maximum displacement 
amplitude (4.5 µm) at approximately .325 mm cavity depth.  
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Figure 11: Influence of metal cap thickness on relative displacement amplitude  
 
 Figure 11 shows the graph that describes the relationship between the thickness of the cap 
and the displacement amplitude, for PZT disk of radii varying from 3 to 10 mm. This figure 
summarizes the data obtained for metal cap thickness ranging from 0.3 to 0.125 mm for a PZT 
radius varying from 3 to 10 mm.  To facilitate the fabrication process 0.125 mm thickness was 
chosen to be the thinnest metal cap modeled, since metal caps thinner than .125 mm are not suited 
for hand manufacturing, although the results in Figure 11, suggests that thinner caps may offer a 
higher displacement. 
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METAL CAP BASE AND APEX DIMENSIONS  
 
In addition to the PZT disk radius, the base radius of metal cap influences the 
displacement amplitude.  As shown in Figure 12, with increasing metal cap base radius (modeled 
from 2 to 9 mm) the maximum displacement amplitude also increases (from approximately 0.8 to 
12+ µm, respectively). The plots in Figure 12 overlap indicating that the metal cap base radius 
plays a more dominant role in comparison with the influence exerted by the PZT disk radius.  For 
instance, if the metal cap base radius were fixed at 2mm, with all other parameters constant, the 
maximum displacement amplitude would be within 5% for all PZT disk radii varying from 3 to 
10 mm.  In Figure 12 the apex radius was kept constant at 1 mm whereas the base diameter was 
varied from 2 to 9 mm (always ensuring that it was 1 mm less than the PZT disk radius). As 
previously mentioned, the reason for keeping the outer radius a minimum of 1 mm less than the 
PZT disk radius was to ensure that an adequate bounding surface was available for the adhesive 
epoxy to be applied during manufacturing.  Also, the choice for making the apex radius always 1 
mm smaller than the base radius was to maintain the desired flexural motion which requires the 
metal cap to retain a “truncated cone” shape.  Figure 13 depicts the influence of apex radius on 
the displacement amplitude and shows that the maximum value is dependent upon the PZT disk 
radius.  For the 10 mm and 3 mm disks the apex radius providing the maximum displacement is 
2.25 mm and 0.75 mm, respectively.  However, as seen in Figure 13, there is less than 5% change 
in the maximum displacement amplitude as long as the apex radius is less than half of the base 
radius. This is most clearly seen with the 10 mm PZT disk radius in Fig. 7 where there is a near 
horizontal trend in displacement amplitude from 0.1-4.5 mm metal cap apex radius dimensions.   
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Figure 12: Influence of metal cap base radius on relative displacement amplitude. PZT radius is 
1mm greater than base radius  
  
 Figure 12 compares the influence of the metal cap base radius, on the displacement 
amplitude of flexural transducers for PZT disk radii varying from 3 to 10 mm. To facilitate 
fabrication and ensure adequate bonding surface for the adhesive epoxy the metal cap base radius 
was modeled such that its maximum value was set to be 1 mm less than the radius of the PZT 
disk. The above result indicates that displacement amplitude is primarily controlled by the base 
radius of the metal cap and to a lesser extent by PZT disk radius (see text for further explanation).    
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Figure 13: Influence of metal cap apex radius on relative displacement amplitude  
 
 Figure 13 examines the influence of the radius of the apex of the metal cap bonded on 
either side of the PZT disk, on the displacement amplitude, and is modeled for PZT disk radii 
varying from 3 to 10 mm. In order to ensure flexural motion the metal cap needs to retain a 
“truncated cone” shape, therefore the metal cap apex radius was always set to be at least 1 mm 
less than the metal cap base radius, here 2 mm less than the PZT radius. 
Figure 13 shows that the apex radius should be several mm less than the metal cap radius, for 
radii > 5 mm, since it can be seen from the figure that the displacement amplitude drops as the 
apex radius increases and approaches that of the disk radius.  
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OPERATING FREQUENCY  
 
 The last parameter considered for device optimization was frequency of operation.  Only 
those parameter sets that had their first eigenfrequency within 10% of the desired frequency of 
operation (i.e. 18-22 kHz for 20 kHz applicator and 90-110 kHz for the 100 kHz applicator) are 
displayed in Figure 14 and Table 1. 
Figure 14 displays a single, yet representative, example demonstrating the dependence of 
the resonance frequency on the geometric dimensions of the flexural transducer as a function of 
the cavity depth.  Resonance frequency analysis was run concurrently with stationary analysis on 
all of the models analyzed.  The models that generated resonance frequencies at 20 and 100 kHz 
were then selected and compared to determine the geometry that produced the maximum 
displacement amplitude at those frequencies. Although several geometries were capable of 
generating 20 and 100 kHz resonance frequencies, the specific dimensions shown in Figure 14 
produced the maximum displacement amplitudes at both 20 and 100 kHz.  
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Figure 14: Resonance frequency vs. cavity depth of transducers  
 
 Figure 14 plots the resonance frequency of flexural transducers, against cavity depth, for 
various PZT disk radii varying from 3 to 10 mm. It can be seen from the figure that 
 (a): For PZT discs with radii ranging from 3 to 5 mm, and the corresponding resonance 
frequency obtained ranges from 50 kHz to 170 kHz. 
(b): For PZT discs with radii ranging from 6 to 10 mm and the corresponding resonance 
frequencies ranges 10 kHz to 30 kHz  
The stars on lines a and b represent the optimal flexural transducer design geometry at the 
frequencies considered here (i.e. 20 and 100 kHz). For the 20 kHz design the FEA analysis 
indicated that the maximum displacement amplitude condition requires PZT disk radii to be at 
least 6 mm (6 to 10 mm radii were modeled here) with metal cap geometric dimensions as 
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follows: base radius from 4.75 to 5.25 mm, an apex radius from 1.5 to 2.0 mm, and a cavity depth 
from 0.25 to 0.30 mm.  For the described metal cap geometric dimensions the PZT disk radius 
had less than 5% effect on the displacement amplitude from 6 to 10 mm, however, when the 
radius became less than 5 mm the peak displacement amplitude started to decline. In Figure 8 the 
dimensions that were selected show just a single geometry ensuring optimal displacement (see 
also Table 1) and for a given frequency of operation (20 and 100 kHz) the displacement 
amplitude at those geometries was in the top 5% of the amplitudes for all the models investigated.  
For the 100 kHz design the optimal dimensions were determined to be 3 to 5 mm for the PZT 
disk radii with a metal cap base radius between 2 and 2.25 mm, a metal cap apex radius between 
0.5 and 0.75 mm, and a cavity depth from 0.225 to 0.325 mm.  Again, the PZT disk radius had 
less than a 5% effect on the displacement amplitude for 3 to 5 mm PZT disk radii when the metal 
cap was fixed at the above-mentioned geometric dimensions, and smaller PZT disk radii were not 
modeled.  
As indicated in Figure 7 - d the ultrasound applicator is primarily operated as array of elements 
and therefore the smallest PZT disk radius that could produce the desired displacement amplitude 
at the desired frequency should have been chosen. However, due to commercial availability of the 
PZT disks as well as the machining tools, the experimental verification of the prototype described 
in [57] used PZT disks having 6.35 mm radius (1/2” diameter). 
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Table 1: – Dimensions for manufacturing an optimized flexural transducer element operating at 
20 and 100 kHz. 
 PZT Dimensions (mm) Metal Cap Dimensions (mm) 
Resonance 
Frequency 
Radius Thickness 
Base 
Radius 
Apex 
Radius 
Cavity 
Depth 
Thickness 
20 kHz 6-10 0.5 5 1.75 .275 0.125 
100 kHz 3-5 0.5 2 0.75 .075 0.125 
 
 
For the 20 kHz design the FEA analysis indicated that the maximum displacement 
amplitude condition requires PZT disk radii to be at least 6 mm (6 to 10 mm radii were modeled 
here) with metal cap geometric dimensions of: base radius from 4.75 to 5.25 mm, an apex radius 
from 1.5 to 2.0 mm, and a cavity depth from 0.25 to 0.30 mm.  For the described metal cap 
geometric dimensions the base radius had the largest effect on the displacement amplitude, with 
corresponding PZT radius ranging from 6 to 10 mm, however, when the radius became less than 
5 mm the peak displacement amplitude started to decline. In (Figure 15) the dimensions that were 
selected show just a single geometry ensuring optimal displacement (see also Table 2) and for a 
given frequency of operation (20 and 100 kHz) the displacement amplitude at those geometries 
was in the top 5% of the amplitudes for all the models investigated.  For the 100 kHz design the 
optimal dimensions were determined to be 3 to 5 mm for the PZT disk radii with a metal cap base 
radius between 2 and 2.25 mm, a metal cap apex radius between 0.5 and 0.75 mm, and a cavity 
depth from 0.225 to 0.325 mm.  
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The experimental verification of the prototype described in [55] and verification of the COMSOL 
model was done by manufacturing flexural applicators with PZT disks having 6.35 mm radius 
(1/2” diameter). Commercial availability of the PZT disks restricts the usable dimensions of PZT 
radii to 6.35 mm (1/2 “ PZT), 8 mm (16 mm PZT) and 10 mm (20 mm PZT). Out of these, the 8 
mm radius PZT offered the most optimized performance, at 20 kHz in terms of displacement 
amplitude and hence this radius was chosen for prototype development. Although the larger - 10 
mm radius disk offered a higher displacement than the 8mm one, it was not chosen because of the 
fragility of the PZT material; the larger the radius the higher is the risk of breaking (damaging) of 
the PZT disc during hand manufacturing.. Table 2 gives the complete list of all the flexural 
transducer geometric parameters used for manufacturing of the optimized ultrasound applicator.  
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CHAPTER 4: MATERIALS AND METHODS 
  
 This chapter describes the transducer manufacturing procedure, materials used, 
experimental setups, and the variety of the measurement and test equipment used to evaluate the 
applicator. The first section gives a concise description of the manufacturing procedure. The next 
section provides a short description of the materials used, and outlines the criteria for specific 
material selection. The methods section describes the test and measurement instruments and 
techniques used.  
 To reiterate, the aim of this work was to fabricate an optimized ultrasound applicator, that 
can be driven using a custom designed driving unit powered by, 12-15 V re-chargeable batteries. 
Completion of Aim 3, to develop a complete tether free, light weight ultrasound applicator patch, 
that is portable, wearable, battery operates and completely ambulatory, along with the results 
from Aim 1 and Aim 2 resulted in the proposed optimized thin (<10 mm thick), light weight (< 
100 g) low frequency (20-100 kHz) therapeutic ultrasound applicator, that is wearable and 
ambulatory in its function, capable of delivering a clinically relevant and FDA approved acoustic 
intensity of 55 kPa (< 100 mW/cm2 , ISPTP). 
4.1 TRANSDUCER MANUFACTURING 
  
 This section gives a pithy description of the overall manufacturing process and then goes 
into the associated manufacturing steps organized into four days, that are required to manufacture 
one array or single element flexural transducer applicator. This section also gives a short 
description of the selection of the different materials used in the process such as PZT, cap metal 
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and bonding and potting epoxy. The transducers and applicators described here were hand 
manufactured in the lab, with displacement optimized dimensions listed in (Table 2)   
 
Table 2: Optimized parameter values used in transducer manufacturing 
  
 
 
 
 
 
 
 
 
 
  
 
Parameter Symbols used in figures and 
descriptions 
Typical values used for 
prototypes 
PZT Thickness T 1.0 mm 
PZT Diameter Ød 16 mm 
Cap Metal Thickness t 0.25 mm 
Apex Diameter Øa 3.75 mm 
Base Diameter Øb 12 mm 
Cavity Height h 0.62 mm 
Cap Thickness=0 .25 mm 
Cavity Depth = 0.62 mm 
PZT Thickness = 1.0 mm 
PZT Radius = 16.0 mm 
 
Base Radius = 11.3 mm 
Apex Radius = 3.75 mm 
Figure 15: Geometry of the single element of the or flexural transducer.  
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Figure 15 and Table 2: Optimized parameter values used in transducer manufacturing 
show and list, respectively, the geometric parameters influencing optimization process for the 
ultrasound applicator considered here, along with the symbols used and the typical values applied 
in the early prototype development.  
  The complete manufacturing process (see details below) required four days, 
including the curing time for the bonding and potting epoxies used at various stages. The 
processes involved can be classified as shaping, bonding and potting. A punch-die was used to 
create brass disks from various thickness (0.125 - 0.25 mm) brass sheets. The metal caps were 
shaped using a custom designed and manufactured shaping die, made out of tempered stainless 
steel.  The shaping die was designed to impart the designed cap dimensions (Table 2) to a circular 
metal (here, brass) disk. These disks were then carefully shaped using the custom-machined 
stainless steel shaping die.  The Navy Type I equivalent (PZ-26 or PZT 840) disks were acquired 
from Ferroperm PZT ( Meggit-Ferroperm, Denmark). A bonding epoxy (Stycast, Emerson and 
Cummings) was mixed as recommended by the manufacturer and then again mixed with silver 
powder to make it electrically conductive.   The epoxy was then used to bond the shaped metal 
caps to both sides of the PZT disk (Figure 15). After the bonding epoxy has cured, silver epoxy 
was used to attach voltage signal wires to both sides of the metal end caps. Such made individual 
elements were then potted in polyurethane epoxy (Spurr's Epoxy), in different spatial 
arrangements. Several – up to 9 – individual elements were combined to fabricate 2x2 or 3x3 
arrays having footprint 35 x 35 or 55 x 55 mm respectively. This footprint can be adjusted 
depending on the specific clinical application needs.   
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Day 1 
   Process I: Punching and Shaping 
  A punch die set and a hand press was used to punch or cut a disk shaped brass piece 
from a sheet of yellow brass, 25 mm thick. The thickness and diameter of the brass disk was 
determined based on the parameter list (Table 1 and Table 2). The maximum thickness used was 
.25 mm, and it was limited by the hand press. Thicker brass could be used with a bigger or 
mechanized press. The disks were carefully sanded using sandpaper with 600 to 1200 grain 
density. The sanding was done to remove any burrs or lips that were introduced in the cutting. 
The sanded disks were checked for deformities, and cleaned carefully with alcohol to remove 
shavings. The disks were then inserted into shaping die that was machined according to the 
dimensions determined by the optimization and FEA modeling. A hand press was used to apply 
even pressure on the disks in order to impart the desired truncated cone shape. The brass caps 
were then removed, measured and grouped according to the uniformity in dimensions.  
 
Figure 16: Shaping metals caps with shaping die and hand press 
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Process II: Bonding PZT and Caps  
 
Figure 18: Metal caps and PZTs 
  
The PZT disks were carefully sanded with 1200-grain sandpaper and cleaned with alcohol to 
expose the electrodes. The bonding epoxy (Stycast- Emerson and Cummings) was mixed 
according to the manufacturer’s suggested ratio as, 1:3 of Stycast 2471 LV to Stycast 15 LV 
respectively. This was also mixed with silver powder in the appropriate proportions (one part per 
weight) to make bonding epoxy mixture conductive. This enables the bonding epoxy to make an 
electrical connection between the printed silver electrode on the PZT disk surface, and the metal 
cap that is bonded on either side.. A layer of this epoxy was applied on both sides of the 
piezoelectric disks and the caps were placed on either side of the PZT, taking care to mark the 
Figure 17: Shaped metal cap 
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PZT polarization, and aligned to be flush with the edge of the PZT disk. The caps are held down 
under pressure to ensure proper adherence and bonding strength for 24 hour. 
 
Figure 19: Bonding caps and PZT 
 
Day 2 
Process III: Electrical connections. 
 
Once the bonding epoxy cured, the individual transducer elements were checked for 
defects and were measured using a network analyzer (AIM 4710 C). The network analyzer 
measurements yield the complex impedance of the transducers over a range of frequencies  (10 
kHz to 50 kHz, for a 20 kHz transducer), and the measurement is recorded. This measurement 
was done to determine the resonance frequency of the transducer, and to group transducer 
elements with similar resonance frequency. Once the grouping was done, the elements were 
placed in to a potting mold of predetermined shape. The mold shape and size determines the final 
shape and size of the applicator and also the shape and size of the active area under the 
transducer. The positive (or negative) sides of the transducer elements were shorted together with 
a lead wire, and an electrical connection is made with the brass using a two part cold solder (MG 
Chemicals). Cold solder was used to ensure proper electrical connection and strength, without the 
PZT getting depolarized due to the localized rise in temperature due to soldering. The solder was 
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allowed to cure for the recommended amount of time (typically 18-24 hours). Once it cured the 
entire assembly was tested to ensure proper electrical connections and the process was repeated 
till the electrical connections are established.   
 
Day 3 
     Process IV: Potting. 
 
 The last step of the transducer manufacturing process is potting the transducer elements 
in a potting epoxy, to ensure structural integrity, electrical isolation and proper transmission of 
the acoustic pressure waves into the tissue at the application area. The potting epoxy used was a 
four-part Spurrs Epoxy. The components of the epoxy were measured by weight in the 
appropriate proportions and mixed well. The epoxy was then degassed in a vacuum chamber, to 
ensure there are no trapped air bubbles in the mixture. The degassed epoxy was then carefully 
poured into the molding die with the transducer elements, ensuring that the electrical connections 
were (properly immersed). The entire mold was then inserted into the vacuum chamber and 
degassed to remove any additional bubbles that got introduced into the epoxy. This was also done 
to ensure that there are no air bubbles trapped under the flexural elements during the pouring. 
Any air bubbles present in the epoxy will expand during the curing process, and the presence of 
air bubbles will render the applicator unusable. This is because the air bubbles impede the 
pressure waves, and they can also displace the flexural elements and affect the acoustic field and 
active area of the transducer.  
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Figure 20 shows an example of a triangular applicator embedded in uncured Spurrs epoxy. The 
flexural elements were arranged in a triangular design, in a round silicone mold, and the epoxy 
was poured into the mold after spraying it with mold release. The entire setup was then carefully 
inserted into a preheated oven set to 70 degree C. The transducer was checked frequently for air-
bubbles, and to ensure that the elements are in place, until the epoxy starts to cure. The transducer 
was allowed to cure for 8 hours.  
 
 
 
 
 
 
 
Figure 20: Flexural elements in potting epoxy in silicone mold 
Figure 21: Mold for a square 2x2 array applicator 
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 Figure 21 shows another example of a silicone mold, and in this case the mold is for a 
square 2x2 array transducer. The flexural applicator can be designed in a variety of shapes and 
sized depending on the size and shape of the active area, the application or other clinical or 
experimental requirements. 
 
  
 
 
Figure 22: Flexural array designs  
 
 Figure 22 shows a few of the tested array designs: From the top, going clockwise, the 
designs are: rectangular shape staggered 1x4 array, square shape single element, circular shape 
single element and circular shape triangular array. Other variations or combination of these array 
designs are possible, and these can be tailored to a given application (in [64], single element and 
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triangular applicators were used). The possible shapes can range from larger arrays like 3x3, 
including 9 single elements to a circular applicator where the individual elements are arranged in 
a ring. 
Day 4: Testing   
 The transducer was removed from the oven and was allowed to cool in air. The finished 
transducer was carefully removed from the mold and was visually inspected for proper alignment 
of the elements and the presence of air bubbles that may have been introduced during the curing 
process. At this stage, any imperfections (such as air pockets, air bubbles, detached electrical 
connections etc.) that are found render the transducer unusable and – as repair is not possible – it 
has to be discarded. The finished transducer was measured to determine the working frequency 
and acoustic output, and was then subjected to rigorous (electro-acoustic) testing procedure, to 
ensure proper and consistent operation. 
 
 
Figure 23: Prototype of the therapeutic ultrasound device with circular shape triangular array 
applicator 
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 Figure 23 shows a completed prototype of the low frequency, low intensity therapeutic 
flexural applicator, which includes circular shape triangular applicator and its driving electronics 
that was used in clinical human trials. The results of these trials are given in [4]. The three-
element triangle applicators were made in a circular mold with the radius of 20 mm. The 
applicator was powered by 12 V Lithium-Polymer (BatterySpace) batteries. 
 
 
 
Figure 24: Prototype of the therapeutic ultrasound device with rectangular shape single element 
applicator; such applicator was used in the experiments of [64] 
  
 Figure 24 shows rectangular shape single element applicator and its driving electronics 
box. The single element applicators were designed specifically for animal [5]- and cell studies [4, 
5], where their smaller (as compared to larger clinical applicators: 40 mm x 40 mm – for 2x2 
arrays)  (20 mm x 20 mm) facilitated the performance of the experiments. 
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4.2 MATERIALS 
 
 This section discusses materials that were used in the flexural transducer manufacturing 
process described above.  
PZT  
 Lead Zirconate Titanate based piezoelectric materials, are the most commonly used, 
commercially manufactured and easily available. Although composite PZTs, and PZT-5H 
materials were considered, eventually PZT 4 or Navy type I ceramic was chosen as the active 
element due to its transmitter-friendly characteristics Especially, the properties of PZT 4 such as 
d33  (~300 x 10-12 m/V), low tangent loss (value) and mechanical quality factor (~500) made it 
material of choice here. Piezoelectric elements from several manufactures including American 
Piezo Ceramics (APC, International), Omegapiezo (State College, PA) and Meggit (Ferroperm, 
Denmark) were tested, and it was determined that with respect to the uniformity and performance 
consistency Meggit’s PZTs discs were superior in comparison with these supplied by other 
vendors. Accordingly, Meggit was chosen as the supplier for all the PZT elements used in this 
work.  
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Table 3: PZT properties 
 
 Table 3 lists the relevant PZT properties of various PZT types; PZT 5H, PZT 5A, PZT 4 
and PZT 8.  
 
METAL CAPS   
 
 As discussed earlier brass was chosen as the cap material for this work. Although  (see 
Figure 9) Aluminum appears to be able to provide even better performance (higher – 3.8 
micrometers - displacement amplitude versus 3.5 micrometers achievable with brass) brass was 
selected because of its ease of machining and use as compared to other metals. Brass can be cut 
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by hand or with the use of a small bench to be shaped by hand press, and can also be shaped using 
a relatively simple stainless steel shaping die, in conjunction with a bench top hand press. In view 
of that it was decided that the additional effort of individually hand machining each aluminum 
cap does not justify the slight – negligible - increase of 0.3 micrometer in displacement amplitude  
  
 EPOXY  
  
 Bonding, silver and potting epoxies are used in the manufacturing process; the bonding 
epoxy is used to bond the metal caps to the PZT ceramic disc and a silver epoxy is used to make 
the electrical connections. The potting epoxy is used to encapsulate the individual flexural 
transducer elements and hence provides mechanical protection for a given geometry of the 
design. In addition to ensuring the structural integrity to the applicator, the potting epoxy also 
electrically isolates the metal caps of the transducer elements from the patients’ skin. 
 
Bonding Epoxy 
 
The bonding epoxy used in fabrication of the applicators was a two part Stycast 2741 LV/15LV 
epoxy, from Emmerson and Cumming., where Stycast 2741 LV is the epoxy and Stycast 15 LV is 
the catalyst that controls the hardness of the cured epoxy. The epoxy was used in the ratio 
recommended for a rigid bond, and this ratio has a hardness of Shore D 82, and a tensile strength 
of 6,900 psi. (47.5 MPa). The epoxy takes 16-24 hours to cure at room temperature, and has a 
usable working time of about 30 minutes, and hence renders itself well for lab based hand 
manufacturing.  
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 The second bonding epoxy used in the manufacturing process was the silver epoxy or 
cold solder. This epoxy was also supplied as a two-component mixture, and provides a strong 
bond with about 900 psi (6.2 MPa) tensile strength, and very low (.017 Ω.cm) electrical 
resistivity.  
Cold solder was used to avoid the thermal damage of the PZT ceramic during fabrication process 
as (heated) conventional solder does not adhere well to the brass of the metal caps and the use of 
the conventional solder would require relatively long exposure of the piezoelectric material to the 
temperatures that might be comparable with the piezoelectric material Curie temperature (200 C 
for PZT4). Cold solder provides heat-free alternative to soldering, and hence was chosen as 
bonding method for making the electrical connections.  
 
Potting Epoxy 
  
The epoxy used for potting the individual flexural elements as a flexural array applicator 
was Spurrs Epoxy. Spurrs epoxy is a four components epoxy that permits hardness control 
according to formulations and ratios in which the four parts are combined (Polysciences, Inc - 
Spurrs epoxy) [65].  Although the reference [62] was published in 1960, the paper, written by 
Arthur Spurrs after whom the epoxy is named, gives a very thorough description of the epoxy, 
and the formula has remained unchanged in the past 50 years. The manufacturer specifies three 
different combinations of the individual parts, that result in three different hardnesses’, namely,  
firm, hard and soft.  In this work several different formulations of the Spurrs epoxy such as 
Spurrs 2, 4 6 and 8 were explored. The table below (Table 4) shows the formulations that were 
examined, in an increasing order of softness, where 8 is the softest and 2 is the hardest. 
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Table 4 : Table shows the rations in which the different components were combined to get the 
epoxy combinations.  
 
 
 
 
 
 
Base    : D.E.R.  (Diglycidyl ether of polypropylene glycol ) 
Polymer  : E.R.L.  (vinyl cyclo- hexene dioxide )  
Softener    : N.S.A. (Nonenyl succinic anhydride ) 
Accelerator : D.M.E.A. (Dimethylaminoethanol ) 
 
The hardness of the epoxy has substantial influence of the final acoustic performance of the 
applicators; it influences both operating frequency and the pressure amplitude. Hence, different 
epoxy mixtures were examined to maximize the applicator’s acoustic output, This was done by 
manufacturing the four test blocks (see Table 4) and evaluating the acoustic properties of the 
different epoxy formulations.  
 To make the test blocks, the procedure recommended by the manufacturers for mixing 
the four parts of the epoxy was followed. The Base (NSA) and polymer (ERL) was mixed in the 
ratio 2.6:1.0 by weight. The Softener or flexibilizer (DER) was then added as per the ratios given 
in Table 1. The amount of flexibilizer added to the NSA:ERL mixture, determines the hardness of 
the cured epoxy. The mixture was stirred and the accelerator was added drop my drop. The drops 
Component 
Spurrs 2 Spurrs 4 Spurrs 6 Spurrs 8 
Base N.S.A 2.6 2.6 2.6 2.6 
Polymer E.R.L 1 1 1 1 
Softener D.E.R. 0.6 1 2 3 
Accelerator D.M.A.E. * 0.04 0.04 0.04 0.04 
  58 
are from a standard 1 ml syringe, and the average weight of a single drop was calculated to be .02 
milligrams, using a high accuracy (.01 mg resolution) scale. The accelerator did not affect the 
physical or acoustic properties of the epoxy. The accelerator controls the time required to cure the 
epoxy and also determines the color of the epoxy. 
 
4.3 MEASUREMENT EQUIPMENT AND SETUPS 
 
 Several different measurement techniques and devices are used throughout the transducer 
manufacturing process. A description of the devices and techniques are outlined in the following 
section. The results of the measurements are given in the next chapter (Chapter 5: Results) 
 
D33 MEASUREMENT 
 
 A D33 meter (Omega Piezo technologies, Inc.) was used to test the PZTs to ensure the 
uniformity in PZT properties. The D33 meter measures the D33 value of the PZT and this is 
measured as unit Charge (Coulombs) per Newton (pC/N) of force applied. The D33 meter applies 
constant force (.25 N @ 110 Hz) across the poled faces of the PZT, and the resulting charge 
produced across the poled faces of the PZT is measured. For a specific type of PZT this parameter 
is constant, depending on manufacturing conditions. For PZT 4, typical D33 is around 300 x 10-12 
m/V +- 10%. The variability in D33 results in variability in the acoustic output and this affects the 
overall performance of the transducer array and uniformity of the pressure field distribution, in 
transducer arrays. Testing the PZTs before bonding ensures that all PZT ceramics used in the 
array applicator design have similar properties thus minimizing the undesirable variability 
between the single applicator elements.  
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Figure 25: D33 Meter 
 
 The D33 meter was also used to test the fabricated single elements, in order to check the 
D33 amplification in the flexural mode of operation. The D33 of ~300 x 10-12m/V  (PZT 4) is 
amplified to around 1000-1200 pC/N (measured using D33 meter) by the flexural transducer 
architecture, and this is in agreement with the displacement amplitude amplification (around 3 
times) discussed in chapter 3. The range of D33 that can be measured by the meter is 1-1000 pC/N. 
This means that the flexural elements cannot be directly measured. This shortcoming is overcome 
by placing a known capacitance in series with the flexural element to be measured. The additional 
capacitance decreases the overall capacitance of the measured element and, reduces the charge 
developed.  
The reason for not using the D33 meter as the primary measurement technique to assess 
the viability of the manufactured flexural elements was that the force is applied directly on to the 
apex of the metal caps and this may result in the caps getting deformed. Even with the lowest 
force that the D33 can apply to do the measurement (.1 N), the shaped brass cap can get deformed, 
and this changes the properties of the flexural element, often in an undesirable way and may also 
render the element unusable. Hence, the D33 meter was not used to test the individual flexural 
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element, and another measurement (complex impedance , see next section) that does not deform 
the metal caps was used to evaluate the single flexural elements. 
  
NETWORK ANALYZER  
 
 A network analyzer was used to measure the electrical properties of the transducer and to 
test the flexural elements, and this was used an alternate to the D33 meter to test the individual 
flexural elements Network analyzers works by applying a time varying frequency signal across 
the face of the flexural elements, and simultaneously measuring the complex impedance of the 
elements.  
A typical plot obtained from the network analyzer is shown below in. It plots the complex 
impedance as resistance and reactance over the frequency range considered, and allows the 
resonance or optimal working frequency to be determined. This frequency corresponds to the 
frequency exhibiting the real resistance, only, or the frequency at which the negative capacitive 
reactance changes to positive inductive reactance.  
 
 
Figure 26: AIM network analyzer  
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Figure 27 : Typical plot obtained from AIM 4710  
 
 Figure 27 shows the typical plot from the AIM 4710 network analyzer. The figure shows 
the results of complex impedance measurement done from 10 kHz to 50 kHz ( x- axis) and the 
top half of the figure shows the plot of the real resistance (orange) and the bottom half shows the 
plot of reactance ( magenta). 
 
MEASUREMENT AND TEST EQUIPMENT 
 
 In addition to the instruments described above oscilloscope, function generator and 
amplifiers were used at various stages of the transducer manufacturing and testing. For 
completeness, these instruments along with the tests, in which they were used, are briefly 
described below. 
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 The oscilloscope is an instrument that is primarily used to view and measure electronic 
signals and waveforms, like the voltage generated in a hydrophone. The oscilloscope used was a 
Tektronix 2202 digital oscilloscope. A function generator (Agilent 32002) was used to generate 
different electronic signal waveforms such as sine wave, triangular wave, square wave etc. The 
function generator was used to generate the excitation waveform that was then amplified using a 
low frequency amplifier (Bruel and Kjaer 2713). The power amplifier was used to test and 
calibrate the applicators, before using them in combination with the battery powered driving 
electronics. The function generator was used in order to manipulate the frequency, amplitude, 
duty cycle and pulse repetition frequency of the tone burst input the flexural applicator during 
testing.  
The power amplifier was specifically designed by B & K to work in the low frequency range (0.1 
- 200 kHz bandwidth) virtually without distortion (Manufacturer’s specs: THF < 0.3) and this 
helped to provide a clean excitation signal to the flexural applicator. 
 
ACOUSTIC MEASUREMENT SETUP 
 
 All acoustic measurements were done in a water tank measuring approximately 100m x 
100 mm x 180 mm, filled with deionized water 18 MegaOhm resistivity. The measurements were 
performed in water to mimic the clinical or experimental conditions. The transducer was also 
positioned in the water tank in such a way that it closely simulated the conditions under which it 
was used in vivo and in vitro.  
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Figure 28: Schematic diagram showing the Ultrasound applicator prototype (multielement array) 
and hydrophone (B&K 8103) measurement setup in water tank  
 
Figure 28 shows the experimental setup used to measure the acoustic properties of the transducer. 
The transducer is placed in the tank so that the transmitting surface is in the water, and the 
hydrophone is held and controlled by a three dimensional XYZ manipulator stage. The 
hydrophone was placed at a distance of 2.5 mm from the transmitting face because it is of 
immediate clinical relevance for such applications as transdermal drug delivery and wound 
management and corresponds to the pressure amplitude experienced by (skin) tissue. For all 
acoustic measurements the applicator was excited or activated using a tone burst waveform, with 
a frequency of ~20 kHz, 50% duty cycle, and 25 Hz PRF. The acoustic pressure wave generated 
by the applicator was then detected and measured using a calibrated hollow cylinder hydrophone 
similar to that described in [66]. This hydrophone was used to obtain the acoustic pressure data 
(discussed in Chapter 5: Results). The hydrophone’s diameter was on the order of 2 mm to ensure 
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that it was substantially lower than the shortest wavelength measured here (15 mm at 100 kHz) to 
minimize acoustic field disturbance. The hydrophone exhibited relatively uniform (+/- 2 dB) 
sensitivity (about 3.83 µV/Pa) in the frequency range 20 kHz – 500 kHz and a useable (-10 dB) 
response between 10 kHz and 800 kHz. 
 
MATERIAL TESTING SETUP 
 
 Material testing was done to determine the properties of the different formulations of 
spurrs epoxy, referred to in this thesis as Spurrs 2, Spurrs 4, Spurrs 6, and Spurrs 8. This section 
describes the test setup, and the results of the tests are given in Chapter 5: Results. The epoxy 
formulations were devised based on the manufacturers guidelines for mixing the four-part epoxy. 
The custom formulations were so designed, that the hardness of the epoxy could be varied, from a 
very hard Spurrs 2 (Shore D 85) to very soft Spurrs 8 (Shore A 30). The setup used for testing the 
longitudinal wave velocity of the epoxy is shown in  
 
 
 
 
 
 
 
 
 
Figure 29: Material testing setup  
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 The figure shows two transducers that are aligned underwater, with each other in all 
directions so that the receiving transducer detects the direct transmitted wave, travelling the 
shortest straight-line path between the two transducers (2.25, 3.5 and 5 MHz, Parametrics 
Transducers) . This was determined by the position of maximum received pressure amplitude. 
The epoxy to be tested was carefully inserted between the two transducers so the ultrasound wave 
travels through the Spurrs epoxy. The ultrasound wave travels through the epoxy, and the time of 
flight for the wave changes, depending on the epoxy properties (speed of sound through epoxy), 
and this information was used to calculate the speed of sound through the epoxy formulation 
under investigation. This was calculated as  
𝐶
𝑚=  𝐷(𝐷/𝑐𝑤)− ∆𝑡 
Where Cm  = speed of sound through the material 
 D = thickness of material  
 Δt = Change in time due to the material  
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CHAPTER 5: RESULTS  
 
 This chapter presents the results of the measurements, tests and the results of the 
optimization performed on the flexural transducer. The first section gives the results of the 
material property measurements on the potting epoxy. The second section describes the 
impedance measurement results and the criterion for element selection and matching for the 
flexural array applicators. The next section shows the results of the optimizations procedures 
described in this thesis and finally this chapter also includes acoustic field distributions of the 
applicators. 
 
5.1 EPOXY: MATERIAL TESTING RESULTS 
 
 This section analyzes the various properties of the Spurrs epoxy formulations used, such 
as longitudinal ultrasound wave velocity through the epoxy, transverse or shear ultrasound wave 
velocity through the epoxy, density of the epoxy etc. This information was also used to determine 
the Lame' constants or Young's modulus of the epoxy material, in order to determine the 
appropriate epoxy within which to pot or encapsulate the flexural transducers.  
LONGITUDINAL WAVE  
 
 Longitudinal velocity was tested using a through transmission with 2.25, 3.5 and 5 MHz 
ultrasound transducers. The primary factor that determined the frequency selection was the 
availability of transducers, and since longitudinal wave velocity independent of frequency, the 
selected transducers were deemed appropriate for longitudinal wave velocity. The experimental 
setup used to determine the longitudinal wave velocity is shown in Figure 29. Several (three) 
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batches of epoxy of each composition were made, and the thickness of each was assessed using 
calipers and screw gauge. Figure 30 shows the resultant longitudinal speed of ultrasound through 
Spurrs epoxy.  The gradual change in speed of sounds reflects the gradual change in hardness of 
the epoxy from Spurrs 2 to Spurrs 8, and this is in accordance with the change in ultrasound 
transmission speed through materials, where the speed of sound is greater in harder materials than 
in soft materials. 
 
 
Figure 30: Longitudinal wave velocity of Spurrs epoxy 
 
 Figure 30 shows the longitudinal wave velocities of the various Spurrs epoxy 
formulations.  As anticipated, the hardest epoxy Spurrs 2 has the highest sound velocity (2288 
m/s) and the softest epoxy , Spurrs 8 has the least ( 1790 m/s) .  
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SHEAR WAVE VELOCITY  
 
 The shear wave velocity or transverse wave velocity of ultrasound was calculated using 
matched pairs of normal incidence shear wave transducers, with 100 kHz 250 kHz frequency, 
(CTS-Valpey Corporation), and the frequencies were chosen to be as close as the operating 
frequency of the flexural applicators. Spurrs epoxy cylinders were constructed to evaluate the 
shear wave velocity, using through transmission between a matched pair of shear wave 
transducers on either side of the test block. The transmitting and receiving transducers were 
directly coupled either side of the Spurrs blocks using special shear wave gel (Sonotech: 54-T04). 
The thickness of the blocks was measured using calipers, and this thickness along with the time 
of flight of shear ultrasound wave through the block was used to calculate the speed of transverse 
ultrasound through the Spurrs blocks. The resulting shear wave velocities are given in Figure 31. 
The shear velocity also shows a trend similar to the longitudinal waves, as expected where the 
velocity increases with increasing material hardness. 
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Figure 31: Transverse/Shear wave velocity of spurrs epoxy 
 Figure 31 shows the results of shear wave velocity measurements in the different Spurrs 
epoxy formulations. The transverse wave velocity also follows a similar trend as the longitudinal 
wave velocity, and the hardest epoxy, Spurrs 2 has the highest velocity of 1000 m/s and Spurrs 8, 
the softest formulation has the lowest velocity of 785 m/s.  
DENSITY 
 
 The density of the potting epoxy (Figure 32) was determined by measuring displacement 
of water to evaluate volume and a weighing scale to measure the weight. The density of Spurrs 
epoxy was found to display a trend that is the reverse of the speed of sound tests, where the 
density of the hardest epoxy (Spurrs 2) was the lowest and the density of the softest epoxy under 
evaluation (Spurrs 8) was the highest. This can be attributed to the ratios of the four part of the 
epoxy, where the DER component was used to control the hardness. The softer epoxy 
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formulations had a higher quantity of DER (the densest) and this contributes to the higher density. 
The result of the density measurement is shown in Figure 32. 
 
 
Figure 32: Spurr's Epoxy Density 
 
 Figure 32 shows the density of the different formulations of Spurrs epoxy. The results 
from the three measurements given above, namely longitudinal wave velocity, shear/ transverse 
wave velocity and density, facilitates the calculation of various physical properties of the epoxy 
such as the Lame constants, Young’s modulus, acoustic impedance etc.  
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EPOXY PROPERTIES 
 
 This sections evaluates the measured properties of the Spurrs epoxy and uses this 
information to calculate the material properties of the epoxy such as the Lame constants,  
Poissons ratio, Young’s modulus and acoustic impedance. 
Acoustic impedance of a material is defined as the product of longitudinal wave velocity and 
density, and it is calculated as  
    𝑧 =  𝜌  𝑐.   
where  ρ = density of the material 
 c =  speed of sound ( longitudinal) through the material 
 
Poisson’s Ratio is calculated as 
𝑣 =  𝑉𝑝2 − 2𝑉𝑠2 2(𝑉𝑝2 − 𝑉𝑠2 )   
Where  Vp = Longitudinal wave velocity of ultrasound in the material 
 Vs = Transverse/shear wave velocity of ultrasound in the material  
The Young's modulus is calculated as  
𝐸 = 2 ∗ 𝐺 (1 − 𝑣) 
where G = the shear modulus 
 v = Poisson’s ratio  
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The Shear modulus is calculated as  
𝐺 =  𝜌 ∗  𝑉𝑠 2   
Where  ρ = Density of the material 
 Vs = Transverse/shear wave velocity of ultrasound in the material 
The P-wave modulus is calculated as  
𝑀 =  𝜌 ∗  𝑉𝑝 2   
Where  ρ = Density of the material 
 Vp = Longitudinal velocity of ultrasound in the material 
And The Lamé parameter can be calculated as 
𝜆 = 𝑀− 2 ∗ 𝐺 
Where M = P-Wave modulus 
 G = Shear modulus  
Table 5: Spurrs epoxy properties: Measured 
Spurrs Epoxy 
Shear velocity 
Vs(m/s) 
Longitudinal 
velocity Vp(m/s) Density (kg/m3) 
        
2 1004 2288 1125 
        
4 967 2216 1138 
        
6 905 2062 1145 
        
8 785 1791 1154 
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 Table 5 lists the measured values of density, longitudinal wave and shear wave velocities 
of the epoxy formulations tested (Section 5.1). It can be seen from the table that the velocities 
follow the same trend as the epoxy hardness which is controlled by the ratio in which the 
different components epoxy is mixed (Section 4.2: Potting Epoxy).   
Table 6: Spurrs epoxy properties: Calculated 
Spurrs 
Epoxy 
P Modulus 
(P) 
Shear Modulus 
 (G) 
Poisson's 
Ratio  (v) 
Young's 
Modulus  (E, 
Pa) 
Impedance 
(z, Rayls) 
            
2 5.89E+09 1.13E+09 0.38 1.40E+09 2.57E+06 
            
4 5.59E+09 1.06E+09 0.38 1.31E+09 2.52E+06 
            
6 4.87E+09 9.36E+08 0.38 1.16E+09 2.36E+06 
            
8 3.70E+09 7.12E+08 0.38 8.81E+08 2.07E+06 
            
 
 Table 5 lists the measured values of density, longitudinal wave and shear wave velocities 
of the epoxy formulations tested (Section 5.1). It can be seen from the table that the velocities 
follow the same trend as the epoxy hardness which is controlled by the ratio in which the 
different components epoxy is mixed (Section 4.2: Potting Epoxy).   
Table 6 lists all the acoustic properties of the epoxy that were calculated (described above, 
Section 5.1: Epoxy properties) based on the measured values. The parameters calculated (and 
listed) are P-modulus and shear modulus (Lamé parameters), Poisson's ration, Young's modulus 
and acoustic impedance.  These parameters were calculated in order to determine whether the 
epoxy formulations govern the acoustic properties, specifically to see if it connected with the 
epoxy hardness.  The epoxy hardness is the primary property that is controlled by varying the 
mixing ratio with which the Spurr's epoxy is made. The calculated parameters in  Table 5 lists the 
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measured values of density, longitudinal wave and shear wave velocities of the epoxy 
formulations tested (Section 5.1). It can be seen from the table that the velocities follow the same 
trend as the epoxy hardness which is controlled by the ratio in which the different components 
epoxy is mixed (Section 4.2: Potting Epoxy).   
Table 6 clearly indicate that all relevant physical properties of the epoxy are controlled by the 
mixing ratio, and that they follow the same trend as the hardness. 
  
5.2 COMPLEX IMPEDANCE MEASUREMENT. 
 
 The impedance measurement was performed using the network analyzer (AIMS 4710C) 
described in the methods section. The hardware in conjunction with the software provides a scan 
of electrical parameters over a frequency spectrum, and for all measurement described in this 
thesis, the scan was done over the range 10 kHz to 50kHz, since the expected resonance 
frequency (~ 20 kHz) falls well within in this range. This range was chosen since it included the 
resonance frequencies of the manufactured elements, which were designed to be 20 kHz. The 
AIMS 4710 network analyzer was used at various stages of the transducer manufacturing process, 
and the results of this complex impedance measurement are given below, in the order in which 
the measurements were performed during the manufacturing process.  
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INDIVIDUAL FLEXURAL ELEMENT 
 
The individual flexural elements were tested with the network analyzer, after the bonding epoxy 
cured. This measurement helps evaluate the properties of the flexural elements, and select the 
ones that will perform the best as single element or array transducers after potting.  This section 
describes three types of flexural transducer elements, classified based on the complex impedance 
measurement using the AIM 4710 network analyzer, namely: typical (Figure 33), ideal (Figure 
34)  and unusable (Figure 35 and Figure 36 ) 
 
Figure 33: Typical impedance scan from a single unpotted flexural element  
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Figure 33 shows a typical plot obtained, and this shows an element with a resonance 
frequency at about 32 kHz. The resonance frequency is distinguishable by the sharp increase in 
resistance and reactance. Figure 27 shows the impedance plot with a well-defined, single 
resonance frequency; the reactance changes from capacitive to inductive at the resonance 
frequency. This is indicative of a well-built flexural element, and this also means that the acoustic 
properties like displacement amplitude and pressure output of this flexural element will be similar 
to the FEA modeling results. This is the ideal scenario and is desirable for all manufactured 
elements show this type of impedance characteristics. However, only 25% of applicators 
fabricated behaved like the one with characteristics shown in figure 33. As described Section 
4.1:Transducer manufacturing, all manufacturing steps are critical. Whereas it is clear that this 
low yield is primarily caused by lack of uniformity in fabrication because of imperfect – hand – 
assembly – it is expected that this yield can be substantially improved once the process is 
automated.  
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Figure 34: Ideal impedance plot of a flexural element 
 
Figure 34 shows an example of an ideal impedance plot. The resonance can be seen at around 
39 kHz, and confirmed by the behavior of the impedance plot. On comparing the plots in Figure 
33 and Figure 34, it can be seen from Figure 34 that the impedance plot looks clean and there is 
only a single well-defined frequency at which the flexural element has its resonance. The 
impedance plot in Figure 33 shows the expected resonance behavior at the applicator resonance.  
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Figure 35: Flexural element with double resonance 
 
Figure 35 shows the impedance plot of an applicator that had to be discarded because of its 
undesirable impedance characteristics. The first indication that this flexural transducer is 
defective is the presence of double resonance. A double resonance appears on the impedance plot 
as resonance behaviors at two different frequencies. In Figure 35, the resonance behavior can be 
seen at ~25 kHz and at ~34 kHz. Double resonances occur when the metal caps on either side of 
the PZT has different shapes. Since the shape of the metal cap controls the resonance frequency, 
each cap introduces a different resonance, resulting in a double resonance. The noisy or uneven 
nature of the impedance plots also indicate the transducer was not properly bonded or that the 
metal caps were not formed or shaped properly.   
 
  79 
 
Figure 36 : Typical example of an unusable flexural transducer impedance characteristics 
 
 Figure 36 shows the typical complex impedance characteristics of a flexural transducer, 
that has to be discarded. The primary reason for this is the absence of the strong resonance 
behaviors in both resistance and reactance, that is seen in Figure 34 and Figure 35. Two instances 
of weak resonance like behavior can be seen in the plot around 20 kHz, and another at around 32 
kHz. This indicates a poorly performing flexural transducer, which cannot be used for applicator 
construction. A double resonance can also be observed, with a weak resonance behavior at 20 
kHz and 32 kHz.  
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POTTED FLEXURAL TRANSDUCER 
 
The second complex impedance measurement (using AIM 4710) was performed after the 
selected individual flexural elements are potted in epoxy. The elements are potted individually as 
single element transducers or in combination as multiple element transducers, in different 
arrangements such as 2x2 arrays, 3x3 arrays, 3 element triangle formations, multi-element 
staggered formations etc (shown in Figure 22 and Figure 23).  
The epoxy potted single and multi-element transducers are measured in the water tank, 
with the transmitting side under water and the other side exposed to air. This was done to 
simulate the conditions under which the applicators will be used in vitro experiments and in vivo 
clinical experiments. The resonance frequency shifts up or down respectively depending on 
whether the transducer was measured in air or submerged in water. Figure 28 shows the 
experimental setup for the acoustic testing of the flexural applicators  
  
Figure 37: Typical impedance plot from a multi-element transducer 
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The Figure 37 scan shows the impedance frequency of the transducer, shown by the resistance 
and reactance plots.  Figure 33, Figure 34 and Figure 35 show the impedance plots from single 
unpotted flexural elements and the main difference between the complex impedance properties 
of the unpotted single flexural transducer and the flexural applicator array was that the resonance 
behavior that was prominent in the unpotted elements was not seen in the potted transducers. 
The resonance frequency of the array applicator is determined by the combined effect of the 
individual flexural elements used to make the array.  
 
5.3 MATCHING 
 
 The complex impedance measured using the network analyzer, provides the information 
needed to implement electrical impedance matching. Impedance matching was realized through 
incorporating passive RC filter in combination with the transducer element, and the parameters of 
the filter were determined using the complex impedance at the resonance or working frequency of 
the transducer. The filter can also be designed to force the transducer to work at a  frequency 
different than the measured resonance frequency, if the applicator does not display a resonance at 
any particular frequency. Hence, this technique can be used to operate the applicators off-
resonance, although at the acoustic performance (input voltage to output pressure conversion) 
reduced in comparison with that  achievable at the resonance frequency.  
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Figure 38: Matched multi-element transducer impedance plot 
 
Figure 38 shows the complex impedance plot of matched applicator that was matched at ~ 26 
kHz, in loaded condition, i.e. transmitting side transmitting into water and the other side open to 
air.  The effects of matching can be prominently seen in the behavior of the cyan reactance plot. 
The introduction of a matching inductor in the series with the applicator causes the reactance to 
increase and change into inductive reactance around the resonance frequency. The ideal situation 
is to get the inductance to match the transducer at its exact resonance frequency.  
 
  83 
 
Figure 39: Complex impedance matching 
 
Figure 39 shows the network analyzer measurements of the early prototype of the ultrasound 
applicator described here. Horizontal axis: Frequency in kHz, Vertical axis: Resistance (Rs) and 
Capacitive Reactance (Xs) in Ohms.   
 
 Matching is critical in determining the usability of the applicator as a batter operated 
wearable therapeutic applicator. The applicators that perform best under testing are the ones that 
can be matched to its exact resonance frequency. A well constructed applicator array made with 
matching single flexural elements, when matched will produce sufficient displacement amplitude 
a 
b 
Frequency (kHz) 
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to produce the clinically relevant pressure amplitude of 55 kPa with <15 V input, even if the 
matching is not done exactly at the resonance frequency. This indicates that matching process 
also plays a role in enabling the applicator to generate 55 kPa pressure amplitude using low 
voltage (10-15 V) battery power supply.  
 
5.4 OPTIMIZED TRANSDUCER  
 
 This section presents the results of the optimization process described in this thesis. The 
optimized transducer applicator was designed and built based on the ideal parameters determined 
from the FEA modeling and the complex impedance matching described above. 
 
Although the measured parameter of the applicator’s acoustic output is pressure amplitude, for 
comparison with the available literature data [10] the hydrophone recorded pressure amplitude 
signal was converted to intensity using a plane wave approximation. As shown in Figure 39 the 
optimized design exhibited spatial-peak temporal-peak intensity (ISPTP) level of 100 mW/cm2 at 
the excitation level of approximately 15-20 VP-P. For comparison, the measurements were also 
performed using the same hydrophone sampling the field produced by a similar ultrasound 
applicator used in insulin delivery experiments described in [10] the only publication that is 
immediately comparable to the design presented here. They required an order of magnitude 
higher (130 V) excitation voltage, which was needed to generate approximately 80 mW/cm2  
(ISPTP) intensity level. 
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Figure 40: Output intensity optimization 
 
An example of the data obtained in water (22°C) with the optimized, early prototype of an 
ultrasound applicator using quasi-continuous wave (CW) and 20% duty cycle. 
a. Over 100 mW/cm2  (ISPTP) achieved with a mere 15 V of excitation voltage. 
b. Corresponding data of a similar applicator design described in [10], the only publication that is 
immediately comparable to this work. An order of magnitude higher (130 V) excitation voltage 
was needed to generate lower, approximately 80 mW/cm2 (ISPTP) intensity level. 
 
 Figure 40 shows input voltage to output pressure conversion of the optimized applicator  
(Figure 40 a) as compared to a similar applicator that was used to obtain the data described in   
(Figure 40 b).  
 
a 
b 
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5.5 ACOUSTIC FIELD DISTRIBUTION  
 
 The acoustic field of the transducer depicts the distribution of the pressure field under the 
transmitting surface of the transducer, measured at a distance of 2.5 mm away from the face, as a 
2D slice at a particular axial distance. The distribution of the field helps create a complete picture 
of what the cells or tissue is experiencing under the experimental conditions. Figure 41 shows a 
typical 2D pressure distribution plot of a flexural transducer, which was measured with a 
hydrophone, in accordance with the procedure described in the methods section. 
The hydrophone (see section 4.3 Acoustic measurement setup) was used to scan a fixed 
area the area under the applicator, with 1 mm resolution, at a distance of 2.5 mm away from the 
transmitting surface.. The pressure at each point is recorded using AIMS software, and this 
pressure data was plotted as color-coded points over the scan area. The color code is distributed 
across the visible spectrum, with violet representing the highest value of pressure recorded, and 
red denoting the lowest pressure reading. 
Figure 41 summarizes the experimental data obtained in water at 22˚C. The pressure amplitude of 
all prototypes was measured using a calibrated hollow cylinder hydrophone similar to that 
described in [66], and this hydrophone was used to obtain all the results presented here. The 
hydrophone’s diameter was on the order of 2 mm to ensure that it was substantially lower than 
the shortest wavelength measured here (15 mm at 100 kHz) to minimize acoustic field 
disturbance. The hydrophone exhibited relatively uniform (+/- 2 dB) sensitivity (about 3.83 
µV/Pa) in the frequency range 20 kHz – 500 kHz and a useable (-10 dB) response between 10 
kHz and 800 kHz.  
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Figure 41 shows the two-dimensional field distribution (XY plane) of the applicator with 
characteristics shown in Fig. 4. The data was recorded at axial distances ranging from z = 2.5 to z 
= 10 mm. The shortest distance (2.5 mm) was chosen because it is of immediate clinical 
relevance for such applications as transdermal drug delivery and wound management and 
corresponds to the pressure amplitude experienced by (skin) tissue. Maximum pressure amplitude 
measured at the axial distance of 2.5 mm was 55 kPa (100 mW/cm2 ISPTP). At the axial distance of 
8 mm, this amplitude was reduced by 3 dB. 
 
 
Figure 41: 2D pressure distribution, 2.5 mm from transducer face 
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In Figure 41, it can be seen that that the pressure distribution follows a pattern of nestled rings, 
with the inner most ring/circle of 3.5 mm diameter experiencing the peak pressure of 55 kPa. This 
is the area directly under the active elements in the transducer. The outer blue ring represents a 
region experiencing a slightly lower pressure of around 45 kPa and the pressure keeps dropping 
as the distance from the active elements increases. This is an example of an ideal acoustic field 
distribution that indicates that the individual elements on the array are similar to each other in 
resonance frequency and characteristics. The field distribution of a single element applicator also 
looks similar to the one shown in Figure 41, and this is because the element is acting alone to 
produce the acoustic field distribution, and mismatch of the flexural elements does not apply. 
 
Figure 42: 2D Pressure distribution, 2.5 mm away from transducer face 
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Figure 42 shows the 2D pressure field from a flexural transducer, that has an elliptical field 
distribution.  The applicators with such as field distribution can also be used as a clinical 
applicator, because the active area of the field is uniform, although in an elliptical shape. 
 
Figure 43: Non-ideal flexural applicator 2D Pressure distribution 
 
Figure 43 shows an example of an uneven pressure field distribution. The two separate 
disjoint regions of maximum pressure can be seen on the top left and right sides, and a third 
region of local high pressure can be seen at the bottom left corner. This sort of a field distribution 
is not ideal, and indicates that the transducer, although functional, is not suitable for clinical 
applications, and hence has to be discarded. This is usually the result of the individual flexural 
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elements that make up the transducer array – individual elements do not have matching resonance 
frequencies or resonance characteristics. 
  
5.6 CLINICAL AND EXPERIMENTAL RESULTS 
 
 Several sets of clinical trials involving human patients with chronic venous ulcers, 
chronic diabetic ulcers, in vivo animal studies for transdermal drug delivery and in vitro cell 
studies were performed with the therapeutic ultrasound transducer described in this thesis. This 
section gives a short summary of all the clinical and in vitro experiments done and their primary 
results and conclusions.   
 
CHRONIC VENOUS ULCERS 
 
 The first set of human clinical trials was done on patients with venous disease, who had 
developed chronic venous ulcers. The clinical trials of venous ulcers were done in two sets, first 
an initial pilot study to determine the exposure parameters and the second to treat a larger 
population of patients with the selected parameters.  
The clinical trials were done to evaluate the effect of low frequency low intensity 
therapeutic ultrasound on chronic venous ulcers, with a total treated population of 25 patients. 
The 25 patients resulted in a statistical power of around 60%, and although this falls below the 
FDA stipulation of 80% power to prove clinical efficiency, the results show a definite positive a 
clinical efficacy that indicated that the therapeutic ultrasound applicator developed as a part of 
this thesis is effective in accelerating the healing of non healing chronic venous ulcers. The 
ultrasound applicator was calibrated to operate at low pressure amplitudes of 55 kPa peak to peak, 
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which is below the lowest threshold recommended by FDA for therapeutic applications (100 
mW/cm2, ISPTP), and this preemptive selection of a safe intensity and the fact that there is no 
representative animal model for chronic venous ulcers helped our research team to get an IRB to 
take the applicator developed directly to human testing.  
The applicator was initially used in a small 20 patient pilot study to narrow down the 
ideal ultrasound parameters to be used The patient population was divided into one sham and 
three treatment groups with different ultrasound exposure parameters. The exposure parameters 
that were changed was frequency, and time of exposure, and the groups were 20 kHz for 15 
minutes, 20 kHz for 45 minutes and 100 kHz for 15 minutes.  
 
Figure 44: Results, pilot clinical study, human trials 
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 The pilot study indicated that although all three ultrasound exposure regiments resulted in 
an overall reduction in the wound size when compared to control, the 20 kHz ultrasound applied 
for 15 minutes, showed a statistically significant  (p < .05). Hence 20 kHz ultrasound and 15 
minutes of exposure was chosen as the parameters for the human trials. Once the parameters were 
determined the larger 25 patient human study was performed with the same ultrasound 
parameters, namely 20 kHz ultrasound, with 55 kPa peak to peak pressure amplitude and 25 Hz 
PRF. 
 
 
Figure 45: Results, 25 patient chronic venous ulcer wound healing, human study 
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Figure 45 shows the rate of change of wound size measured as cm2/week. The wound 
size is measured as the area of the wound and this is determined by using matlab to measure the 
area of the wound, inside a hand traced periphery of the wound picture. The results show that in 
the wounds treated with ultrasound the area of the wound reduced by an average of 7.5 cm2  per 
week, as compared to the sham treated, or control, where the wound size increased by an average 
of 2.5 cm2 per week. These statistically significant results indicate that low frequency low 
intensity ultrasound has a positive effect on chronic wounds, making them heal faster, or by 
slowing down the rate of wound size increase.  
 
CHRONIC DIABETIC ULCERS 
 
 The therapeutic applicator was also used to do a preliminary human study, on chronic 
diabetic wounds. The parameters used were similar to the parameters that showed a positive 
effect on chronic venous ulcers, i.e. 20 kHz ultrasound at 25 Hz PRF. 
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Figure 46: Results, 8 patient diabetic wound healing, human study 
 
 Figure 46 shows the results from the small patient human study, and the results show that 
the low frequency low intensity therapeutic ultrasound applicator was effective in accelerating the 
healing of chronic diabetic ulcers. The group that received the ultrasound treatment had their 
wound reduce in size by an average of 31 cm2  / week whereas the control group that received no 
treatment had an average reduction of only 6.8 cm2 / week. Although these results are with a 
small patient population of 8 patients, the trends shows by the data makes the results very 
promising and it does indicate that the ultrasound applicator described in this thesis is also 
effective in bringing about a positive effect on chronic diabetic ulcers.  
 The results, shown in Figure 45 and Figure 46, demonstrate the need for a clinically 
applicable low frequency therapeutic ultrasound applicator, like the one describe in this thesis. 
The clinical results give more validity to the conclusions as opposed to testing the applicator on in 
vitro cell cultures.  
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TRANSDERMAL DRUG DELIVERY 
 
 The ultrasound applicator described here was also used to test the role of ultrasound in 
transdermal needle free drug delivery. The drug delivery experiments were performed on an in 
vivo animal model (CD-1 Mice). Two different experiments were performed, and the first one 
evaluated the effect of ultrasound on transdermal drug delivery in terms of reduction in paw 
swelling. The effect of ultrasound alone, betamethasone alone and betamethasone delivery with 
ultrasound, were compared to control and it was determined that the combination of ultrasound 
and betamethasone showed the best therapeutic effect (reduction in swelling). The results are 
shown in Figure 47. The second study evaluated the effect of the therapy by looking at the 
inflammation using a infrared fluorescent imaging. This technique showed that ultrasound alone, 
and betamethasone in combination with ultrasound both reduced the inflammation when 
compared to control.  The results of the study are briefly described below, along with the results. 
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Figure 47: Results, Transdermal drug (Betamethasone) delivery, animal study 
 
  Figure 47 shows the effect of low frequency US combined with betamethasone topical 
administration on carrageenan-induced arthritis in a mice model.. Male CD1 mice received 
topical administration of 25 mg/kg mice betamethasone combined with 20 min exposure 
of low frequency US (n=11), 1 hour prior to carrageenan injection. Control mice received 
topical administration of 25 mg/kg mice of betamethasone (n=10), 20 min exposure of 
low frequency US (n=10) or left untreated (n=11). Three-(3) mg/kg carrageenan was 
injected into the sub-plantar area of the mice left hind paws. * p<0.05 compared to paw 
swelling of mice treated with US; * p<0.05 compared to no treatment.  
The study indicated that low frequency; low intensity ultrasound can assist in topical 
delivery of anti-inflammatory RA drugs such as betamethasone. In this study, an 
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enhancement of betamethasone delivery by US was observed. However, the proof of 
concept presented in this pilot study indicates the need for additional experiments 
systematically evaluating and optimizing the potential and efficacy of delivery.  
 
 
Figure 48: Results, transdermal drug (betamethasone) delivery, animal study 
 
Figure 48 shows the results from near infrared fluorescent imaging of paw glycolic activity in 
carrageenan-induced arthritis in mice model. 
 One hour after the carrageenan treatments previously described, mice were injected with 10 nmol 
of IRDye 800CW-2 DG via the tail vein. Images were taken 2 hours after the optical imaging 
probe, IRDye 800CW-2 DG , injection via the tail vein. The infrared imager images were 
processed using Applied Spectral Imaging Software, Spectral View. Intensity scale: high intensity 
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signal is shown in red; intermediate intensity signal, green; low intensity signal blue. The NIR 
intensity was estimated at identical conditions for all mice. * p<0.05 compared to  US treated 
group, * p<0.05 compared no treatment group;  * p<0.05 compared to betamethasone treated 
group. 
 
 These results from transdermal drug delivery experiments (Figure 47, Figure 48) show 
that the applicator can also be used effectively to deliver drugs without the syringes, paving the 
way to other applications like insulin delivery, liposome encapsulated drug delivery, etc. 
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CHAPTER 6: DISCUSSION AND FUTURE WORK 
 
 This chapter discusses the constraints, setbacks, variabilities and errors associated with 
the experiments and procedures described in this thesis. Mainly the discussion section of this 
chapter gives a summary of all of the issues related to transducer manufacturing and applicator 
development. The future work section gives suggestion for modifications, improvements and 
possible future directions for the flexural applicator described here. 
 
6.1 DISCUSSION 
 
 The first part of this section goes into limited details about the issues associated with 
hand manufacturing the transducers, and the drawbacks of the process. The section also describes 
the constraints and limitations associated with the manufacturing the flexural transducers, and 
development of the therapeutic ultrasound patch.  
 
Shaping die Machining:  As noted earlier in the transducer manufacturing section, the 
flexural transducers are PZT discs that are bonded on either side with shaped metal caps. The first 
limitation, is the shape and size of the PZTs being used, and hence the shape and size of the metal 
caps. The dimensions of the metal cap geometry that was used to manufacture the flexural 
elements described in this thesis can be found in Table 2. These metal caps are shaped using a 
custom designed and machined stainless steel die. The machining of the die presents a major 
challenge, because of the small geometric dimensions. The smallest dimension, cavity depth is 
.625 mm or .025 inch, and the precise machining of this and the other dimensions depends 
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primarily on the availability of the right dimension machine tools, high precision mills and lathes 
that can move in one thousandth of an inch steps, and finally the skill of the machinist. These 
factors are often uncontrollable in a lab environment and this affects the accuracy of the 
machined shaping die. This shaping die is used to impart the truncated cone shape to the metal 
cap, and the errors and inaccuracies in machining the shaping die is passed on to the shaped metal 
cap.  
As it was shown by the FEA modeling, the resonance frequency and the displacement 
amplitude both depend on the dimensions of the shaped metal cap. So, although the FEA 
optimization process can provide an ideal set of geometric dimensions to use to obtain the 
expected result, the machining process and its limitations restricts the practically attainable 
optimized geometry. This also means that the manufactured flexural applicator cannot perform at 
the highest possible displacement amplitudes modeled by the finite element analysis, and the 
machining and the metal cap geometry is one factor that contributes to this.  
 
Metal Caps: The metal discs that are used in conjunction with the shaping die, to make the 
shaped metal caps for the flexural transducer, are punched as metal discs from a sheet of brass, 
using a punch die. The punch die, and the punching process that is used to make the metal discs 
present the second source of error in the manufacturing process. The punching tool (Precision 
Brand, punch and die set) is cylindrical stainless steel punch, and one of the ends is flat and the 
edges are sharp, and this in combination with a hollow cylinder receptacle base forms the punch 
die set. The brass sheet is inserted into the base and a small hand press is used to punch out the 
brass discs one by one. The hand press is not ideal for exerting uniform and controlled pressure, 
and the process can often introduce burrs or lips at the edges of the punched metal discs, as a 
result of shearing the metal apart instead of cutting it. This shearing effect is also intensified by 
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the punch tool’s cutting edge loosing its sharpness and becoming rounded with use. The lips are 
hard to remove, and often result in the disc getting slightly deformed and also loosing the perfect 
circular shape during the sanding process. This affects the final quality of the shaped metal caps 
and the shape of each individual metal cap ends up slightly different. These differences lead to 
double resonances in the flexural elements, and sometimes also uneven or no resonance structure 
(see Figure 35). This renders many bonded flexural elements unusable and thus affects the yield 
of the manufacturing process (see more details below). 
Epoxy: The bonding process also presents some challenges and brings in additional uncertainty 
to the output and performance of the flexural elements. The properties of the bonding epoxy 
(Emmerson and Cumming Stycast 4710 LV, materials section) depends on several parameters, 
namely, ratio of the mixture, uniformity of mixing, particulates present in the air, amount of 
moisture in the air etc. These factors determine the final properties of the cured epoxy, and in a 
lab environment these variation can introduce differences between batches of transducers, 
depending on conditions like air quality in the lab, humidity etc. It is conceivable that the “clean 
room” assembly conditions would reduce the variability in the acoustic performance between the 
applicator batches.  
  
Yield: The major limitation of the early prototype manufacturing process in the conventional 
laboratory environment is the “production” yield. The yield of the applicators was initially 
calculated to be around 25 %, which means almost 75% of all flexural elements wound be 
rendered unusable at the end of the manufacturing process, and to make a 2x2 array transducer 
with four elements, sixteen individual flexural transducers would have to be manufactured. The 
flexural applicator can be designed and constructed as an array of individual flexural elements in 
order to control the active area of the final therapeutic applicator. The array applicator require that 
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the elements of the array be identical to each other in terms of resonance frequency, impedance 
characteristics etc, for the final applicator field to be uniform, and for the applicator to deliver the 
intended acoustic energy. As a result of the components’ variability mentioned above, the 
individual flexural applicators are never identical, and the actual resonance frequency, and the 
value of resistive and capacitive reactance at that resonance frequency varies between flexural 
transducers. The yield was improved to approximately 75% by designing the optimized set of 
parameters for manufacturing the flexural transducers and by carefully reviewing and controlling 
the variability associated with each step of the manufacturing process 
6.2 FUTURE RECOMMENDATIONS 
 
 This section discusses changes and improvements proposed to optimize the fabrication 
process and performance of the ultrasound applicators. 
 
Manufacturing:  The process of manufacturing a flexural transducer is a relatively arduous 
step-by-step procedure that can be streamlined further by minimizing the reasons of components 
variability and this would require automation of the process. Specifically, the process of punching 
and shaping the metal discs would be much more precisely controlled by mechanized press, that 
would deliver the same amount of force every time, and hence would virtually reduce the 
variability in metal cap shapes. By using techniques similar to those employed in screen-printing 
the mixing volumes of bonding epoxy could be carefully controlled. The fabrication should be 
performed by using a designated clean room, with controlled temperature and humidity, which 
have critical influence of the final properties of potted and bonding epoxies and hence on the 
uniformity of the acoustic output of the applicators.  
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Therapeutic applicator: The clinical trials described in this thesis were performed with first 
and second-generation of early prototype ultrasound applicators, and these prototypes need to be 
improved. In addition to the mechanical design discussed above, the electronic driver circuitry 
could be streamlined. Specifically, the electronic driver circuit of the applicators described here 
makes use of a PIC (Programmable Integrated Circuit) microcontroller, that could be fully 
programmed to make the ultrasound parameters like PRF (pulse repetition frequency) and duty 
cycle continuously variable and patient controlled, While keeping the maximum acoustic energy 
at the safe level, this would in general enable the amount of acoustic energy delivered to be 
adjusted or controlled. It is plausible that even lower levels of acoustic pressure amplitude than 
the one used in this work (55kPa) could prove beneficial in applications considered here (wound 
healing and drug delivery) 
 
Materials: The materials selected for applicator manufacturing were chosen considering their 
availability, cost and hand-machining properties.  The PZT-4 piezoelectric ceramic was 
considered as adequate for the early prototypes, however, the applicability of composite PZT 
ceramic should be examined. Composite PZT materials exhibit up to 30 % higher (in comparison 
with the conventional ones used in this work) transmitting constants, so it is conceivable that for 
the same acoustic output the excitation voltage could be lowered. This, in turn, would permit 
lower battery voltage to be used and lead to reduction in the requirements of battery capacity 
(V•A), and – in turn -  reduce the weight of the wearable applicator.  
Finally, in view of the European Community directive suggesting severe limitations, if not a total 
ban, of lead, including lead-based ceramics [62], the performance of the ultrasound applicators 
using lead-free ceramics that are currently under development [63] should be modeled and 
investigated.  
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Ultrasound exposure parameters: The exposure parameters employed in this work should be 
extensively investigated in vitro (for instance using fibroblast cells) in order to determine the 
ideal ultrasound exposure parameters that can bring about the most desirable clinical outcome. 
The range of parameters explored in in vitro and in vivo studies were; frequency (~20 kHz and ~ 
100 kHz), PRF (1 Hz, 10 Hz and 25 Hz) and total exposure time (15 minutes and 45 minutes). It 
is conceivable that there could exist a specific frequency, PRF, duty cycle or exposure time, or a 
very specific combination of these parameters that will result in the most ideal or desirable 
clinical outcome. These parameters could be identified in two ways. The first is to systematically 
vary each of these parameters one by one, and in combinations while keeping the in vitro 
experimental conditions constant. The second is to determine the mechanisms of action of 
ultrasound and tissue interaction that brings about the clinical change (accelerated wound healing) 
and then fine tune the ultrasound exposure parameters based on the unveiled cellular mechanisms 
of ultrasound. 
 
Applications:   The low frequency (< 100 kHz) low intensity (< 100 mW/cm2) 
therapeutic ultrasound applicator that was developed as part of this thesis work, has been 
successfully used in clinical human and pre-clinical small rodents trials, and cell models, and had 
proved its effectiveness in bringing about a beneficial biological effect. Although the applicator 
has only been proven effective in chronic wound healing, transdermal drug delivery and 
promotion of cell proliferation, the potential applications areas extend beyond these three 
applications. It is conceivable that the same applicator can be used for applications such as 
pressure ulcers, nerve stimulation, pain relief, delivery of topical drugs, etc. The future work that 
can be done as a continuation of this project should also include testing the applicator for a wider 
variety of applications, to tap the full potential of low frequency, low intensity therapeutic 
ultrasound. 
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APPENDIX 
DRIVING UNIT - BASIC ASSEMBLY 
 
This section gives a short description on the assembling the driving unit for the flexural 
applicator.  
Print and acquire printed circuit board (PCB), based on the PCB layout 
Prepare all electrical components for setting up the driving circuit ( 
Program the PIC microcontroller to set the PRF (~25 Hz) and duty cycle (50 %) 
Mount components on the PCB 
 
Figure 49: Populated PCB board 
 
Mount matching inductors, based on the measured impedance (measured at the frequency of 
operation) of the flexural transducer being used.  
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Connect battery and verify the output frequency (~20 kHz ), duty cycle (50%), PRF (25 Hz) and 
output voltage (5-10 V)  on the oscilloscope  
Connect the applicator and test in water for the acoustic output at about 2 mm axial distance. (see 
section 4,3 Acoustic measurement setup) 
 Verify whether the voltage measured is 210 mV (corresponding to 55 kPa (peak-peak) pressure 
amplitude using the oscilloscope.  
Hydrophone (Reson 4038) conversion ratio is 3.8 μV/Pa, for 20 kHz (Modify conversion ratio 
according to applicator's actual frequency of operation)  
Test for directivity pattern (field distribution): if similar - to within +/-10% - to the one shown in 
Figure 41: 2D pressure distribution, 2.5 mm from transducer face, Section 5.5 Acoustic field 
distribution, the applicator operates properly. If not, it cannot be used for patient exposures. 
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TRANSDUCER FABRICATION MATERIALS 
 
I. Caps 
Name:   TruPunch Punch & Die Set 
Vendor:  Precision Brand 
Website:
 http://www.precisionbrand.com/ProductsCatalog/PBPCategoryDetails.aspx?Catid=191 
 
Name:   Hollow Punches 
Vendor: Mayhew Tools 66000 
Website: http://www.drillspot.com/products/76743/Mayhew_66002_Hollow_Punch_Set 
Comments: Use only 0.5” punch.  Use with hammer/punching machine. 
 
Name:  Brass sheet 
Comments: Use only 0.2-0.7mm; depends on array dimensions 
 
Name:  Shaping die 
Vendor:  N/A, machine shop-made 
 
Comments: Pressure used (60 psi) depends on material used 
 
 
II. PZT 
 
Name:  Piezo electric material  
Vendor: Meggit-Ferroperm, Denmark 
 
Name:  Epoxy (STYCAST 2741LV Black) 
Vendor:  Emerson and Cuming 
Website:
 http://www.ellsworth.com/display/productdetail.html?productid=632&Tab=Vendors 
Comments:  
 
III. Epoxy  
 
Name:   Epoxy (STYCAST 15LV Black)  
Vendor:  Emerson and Cuming 
Website:
 http://www.ellsworth.com/display/productdetail.html?productid=600&Tab=Vendors 
 
 
 
 
Name:  Spurrs epoxy 
Vendor: SPI chemicals 
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IV. Connections 
 
Name:  Connection wires  
Vendor: McMaster-Carr 
Website: www.mcmaster.com/ 
Comments: PS0043, AWG 26 
 
 
Name:  Silver epoxy 
Vendor: Von Roll Isola 
  PO Box 1404 
  New Haven, CT 06505 
Website: http://www.vonroll.com/ 
Comments: E-Solder No. 3022 Conductive Adhesives 
 
V. Casting 
 
Name:  Ease Release 200 Mold Release 
Vendor: Mann 
Website: http://www.utrechtart.com/dsp_view_product.cfm?Item=62028 
 
 
Misc 
 
Cotton swabs  
Mat 
Sandpaper (≥400 grain) – to rub white powder off PZT 
Clips – to hold cymbals in place while epoxy dries 
Disposable plastic beakers – for epoxy mixing 
Single stranded wire – for connections between cymbals 
Weighing dishes 
Soldering iron 
Silicone – mold casting  
Ethanol 
Kapton tape  
 
 
Table 7: Physical properties 
of end cap materials 
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HYDROPHONE CALIBRATION CHARTS 
 
 
 
 
 
Figure 50: Reson 4038 Calibration chart 
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Figure 51: Bruel and Keur calibration chart, voltage sensitivity 211.1 dB re 1V/uPa 
